Registered Members Login:
   
Forgotten Your Details? Click Here To Recover +
Welcome To The ShareCafe Community - Talk Shares And Take Stock With Smart Investors - New Here? Click To Register >

2 Pages (Click to Jump) V   1 2 >

bing
Posted on: Mar 27 2013, 02:55 PM


Group: Member
Posts: 304

What the heck is happening with Pharmaxis .

How much can it drop further? Today it fell as low as 31.5c , a drop of 5cents !!!!!!!!!!

Perhaps this has something to do with it >>>>>>> Dr Alan Robertson steps down and will leave the Company after 13 years of service

  Forum: By Share Code

bing
Posted on: Oct 20 2011, 01:49 PM


Group: Member
Posts: 304

18th October 2011

BREVAGen Launch in US

GENETIC TECHNOLOGIES’ BREVAGen™ CHANGING THE WAY US PHYSICIANS ASSESS BREAST CANCER RISK
Positive early endorsement by physicians and staged US roll-out on track

http://www.gtglabs.com.au/images/stories/p...cancer_risk.pdf
  Forum: By Share Code

bing
Posted on: Sep 9 2011, 09:57 AM


Group: Member
Posts: 304

I looked up the details of the Share Buy Back,

here they are,

Tuesday, 30 August 2011
Last day that Shares can be acquired on the ASX to be eligible to both:
* participate in the Buy-Back; and
* qualify for franking credit entitlement in respect of Buy-Back consideration.

Wednesday, 31 August 2011
Ex-Entitlement Date: Shares acquired on the ASX on or after this date will generally not confer an entitlement to participate in the Buy-Back.

Tuesday, 6 September 2011
Record Date: Determination of shareholders entitled to participate in the Buy-Back .

Friday, 9 September 2011
Mailing of Buy-Back Documents to shareholders expected to be completed.

Monday, 26 September 2011
Tender Period opens

Tuesday, 27 September 2011
Payment of the Final Dividend.

Friday, 14 Ocotober 2011
Closing Date: Tender Period closes. Tenders musat be received by the Perpetual Share Registry no later than 7:00pm, Sydney time.

Monday, 17 October 2011
Buy-Back Date: Announcement of the Buy-Back Price and scale back (if Any)

Friday, 21 October 2011
Dispatch/crediting of Buy-Back proceeds to participating shareholders completed.
  Forum: By Share Code

bing
Posted on: Aug 1 2011, 08:17 PM


Group: Member
Posts: 304

Did a bit of trading today

Share price up 15c or 13.64% in one day, finished at $1.25. WOW!!1

Any news?

Where will it end up tomorrow?
  Forum: By Share Code

bing
Posted on: Jul 11 2011, 09:19 AM


Group: Member
Posts: 304





Cellestis Limited Announces Improved Proposal by QIAGEN N.V.
  Forum: By Share Code

bing
Posted on: Jun 6 2011, 04:41 PM


Group: Member
Posts: 304

Nice run today reaching a high of $1.225

Maybe there is another spike occurring tomorrow.
  Forum: By Share Code

bing
Posted on: Jun 1 2011, 10:33 AM


Group: Member
Posts: 304

[size="4"][/size]MAK in a trading halt?

What's happening now?


  Forum: By Share Code

bing
Posted on: May 30 2011, 04:29 PM


Group: Member
Posts: 304

[b]Did a bit of trading today and obtained a nice packet.

Bought on Friday at 91c and sold today at $1.30 and bought again before 4pm at $1.14.

Hope tomorrow will see a simlar run.
[b]
  Forum: By Share Code

bing
Posted on: May 11 2011, 10:33 AM


Group: Member
Posts: 304

Something to think about!

Mesoblast Pty Ltd (MSB) shareprice keeps going higher and higher.

May 2010 $1.90 and May 2011 $9.80, a rise of 415% !!!!

No P/E because they are still burning cash.

How come Cellestis is performing so poorly in comparison,
despite making a profit and paying dividends.
  Forum: By Share Code

bing
Posted on: May 3 2011, 10:17 AM


Group: Member
Posts: 304

Yes you are correct but I was pointing to the licencing which GTG has
granted to Qiagen and Cellestis could have done the same, rather then selling out!

  Forum: By Share Code

bing
Posted on: May 2 2011, 06:25 PM


Group: Member
Posts: 304

Genetic Technologies grants licence to QIAGEN

Why can't Cellestis do this???

http://www.businessspectator.com.au/bs.nsf...nt&src=srch

Genetic Technologies share price went up 72% this year and again today 25.81%, something for Cellestis to copy!!!

  Forum: By Share Code

bing
Posted on: Feb 22 2011, 08:03 PM


Group: Member
Posts: 304

Picked up this report recently from Lincoln Indicators – Stock Doctors

Analyst Comments For Period Ended December 2010:

Follow-up to Half Year Profit Release€ - Lincoln Valuation Upgraded from $2.58 to $2.91

CST has retained its Star Stock status following analysis of the company's latest interim results. In addition, we attended a briefing were the CEO outlined the company's prospects, strategy and focus. As a result of these developments, we have increased our Lincoln Valuation to $2.91.

The company remains in a position of Strong financial health. Due to strength in the profitability, cash flow generation, and low gearing, CST is exposed to manageable€ levels of financial risk and therefore satisfies Golden Rule No. 1 - Financial Health.

Net operating profit before tax and significant items has risen by 46.37% from $3.872 million in the previous corresponding period to $5.666 million.

Pre abnormal Earnings per Share (EPS) increased 30.3% to 4.3 cents. Return on Assets (ROA) improved from 25.95% to 34.42%. With ROA trending upwards and EPS growth above the 8% benchmark, CST is able to satisfy Golden Rule No. 2 - Management Assessment.

Market capitalisation is $264 million hence satisfies Golden Rule No. 6 - Market Capitalisation.

Despite€ negative impacts from currency, revenues grew 24% in Australian dollars. Encouragingly, revenue grew across all regions, including the key US market. The US is the most active developed country in terms of control of Tuberculosis, with 18 million tests performed annually.

Currently CST sells approximately 1 million QuantiFeron TB tests (QFT) in the US, and going forward this market is going to be an area of great focus.

In the€ half year, interim dividend increased to 2 cents from 1.5 cents in the previous corresponding half. CST generates robust cash flows and we expect that the company in its current form can continue to grow dividend payments. At the briefing the€ company announced that it is open to synergistic mergers and acquisitions though there were no deals on the horizon.

While€ we are optimistic about CST's prospects, we caution that currency headwinds will impact earnings in the short term. Furthermore, the ability to grow earnings at astronomical levels will decrease as the QFT technology penetrates its target markets.

Half Yearly Report and Accounts 14-Feb-2011



  Forum: By Share Code

bing
Posted on: Jan 24 2011, 03:10 PM


Group: Member
Posts: 304

Denmark's Statens Serum Institute

says it has found a TB vaccine that protects before and after exposure!

http://www.bbc.co.uk/news/health-12224172


worthwhile reading!

What impact may this have on Cellestis?
  Forum: By Share Code

bing
Posted on: Jan 24 2011, 02:57 PM


Group: Member
Posts: 304

After all this news I purchased quite a lot of shares, hoping it will perform in
the next 12 months.

Based on a investment report last year from Macquarie Research expecting that iSoft's
12 months price target could be 58c.
  Forum: By Share Code

bing
Posted on: Jan 24 2011, 02:48 PM


Group: Member
Posts: 304

Directors leave iSoft

Date: 4 January 2011
Author: Brian Corrigan
Source: The Australian Financial Review --- Page: 40
Software development company, iSoft, has lost two non-executive directors.Claire Jackson
(been there 6 yrs)and Peter Wise (been there 11 yrs) told shareholders at the company's
AGM that they wanted to leave. Their departure was confirmed in a note to the Australian stock
exchange on 31 December 2010
  Forum: By Share Code

bing
Posted on: Jan 24 2011, 02:46 PM


Group: Member
Posts: 304

iSOFT Group director buys on-market

Published 3:20 PM, 5 Jan 2011
Source: News Bites

iSOFT Group Ltd director Ronald Charles Series indirectly bought 400,000 shares for $30,053 on-market on December 29, 2010.

He indirectly holds 400,000 shares.

STOCK DASHBOARD: January 05, 2011

Isoft Group

Price at 2:00 pm: 7.10c

Price change from previous trading day: -2.7%

Relative Strength (6 months percentile rank): 0.4

Market capitalisation: $76 million

Turnover volume: 625,086.0

Volume Index (1 is average): 0.1

Turnover value: $45,376

Turnover period: 7 months

Value of $1,000 invested 1 year ago: $97

Source: www.BuySellTips.com
----------------------------------
iSoft Group director buys on-market

Published 5:38 PM, 3 Dec 2010
Source: News Bites

iSoft Group Ltd director Peter John Housden indirectly bought 125,000 shares for $10,125 on-market on December 1, 2010.

He indirectly holds 125,000 shares.

STOCK DASHBOARD: December 03, 2010

Isoft Group

Price at 4:20 pm: 8.20c
  Forum: By Share Code

bing
Posted on: Oct 1 2010, 12:03 PM


Group: Member
Posts: 304



Major shareholder lashes iSoft for poor performers



In today's The Australian newspaper

http://www.theaustralian.com.au/business/m...x-1225932549570
  Forum: By Share Code

bing
Posted on: Oct 1 2010, 11:58 AM


Group: Member
Posts: 304

iSoft's CEO quits after $383m plunge into the red

Article from The Australian, 1st September 2010


http://www.theaustralian.com.au/business/i...x-1225912536337
  Forum: By Share Code

bing
Posted on: Sep 23 2010, 01:35 AM


Group: Member
Posts: 304

Disappointment risk: Aussie dollar '27% overvalued'

http://www.smh.com.au/business/markets/dis...0920-15i8l.html

Here is a very good article!

Seems that the Aussie dollar could come down soon.
  Forum: By Share Code

bing
Posted on: Sep 15 2010, 11:35 PM


Group: Member
Posts: 304

<h1 class="story-header">UK scientists devise 'one-hour test' for TB</h1>


http://www.bbc.co.uk/news/health-11297640
  Forum: By Share Code

bing
Posted on: Aug 24 2010, 10:10 AM


Group: Member
Posts: 304

The bottom has really dropped out this time!!!

What's going on ?
  Forum: By Share Code

bing
Posted on: Jul 15 2010, 08:54 PM


Group: Member
Posts: 304

http://interceder.net/i/ISOFT
  Forum: By Share Code

bing
Posted on: Jul 15 2010, 08:44 PM


Group: Member
Posts: 304

From Smartcompany website



http://www.smartcompany.com.au/finance/20100714-isoft-makes-yet-another-profit-downgrade-fuels-speculation-of-private-equity-bid.html






iSoft makes yet another profit downgrade, fuels speculation of private equity bid



Wednesday, 14 July 2010 10:34

By Patrick Stafford





Troubled software maker iSoft has announced yet another profit downgrade, the second since June, with the company reportedly letting go about 600 staff.



The announcement comes after reports were published suggesting a number of private equity firms are eyeing the company, as its market value has plummeted to just $170 million from a peak of about $1.5 billion.



In an announcement to the Australian Securities Exchange yesterday, chief executive Gary Cohen said the current estimate for the 2010 year is revenue of about $430 million, with EBITDA of approximately $40 million before "exceptional and one-off items".



This comes after a profit downgrade was made in early June, with the company then announcing an expected revenue level of $440-445 million, a decline from a previous downgrade to $500-520 million.



When the June announcement was made, iSoft shares plummeted to a year low of 39c, and then continued to 35c. Today they sit at just 16c, representing a massive 75% decline over the year to date.



Cohen said in a statement that the development of the Lorenzo project has been continually delayed, and development work will go on until 2012.



"This had led to an accounting adjustment of the revenue recognised to June 30, 2010 of $4.1 million. This adjustment does not have any cashflow impact. The additional time required for delivery will mean that the revenue recognition of milestones, which are a fixed amount, under the percentage of completion method, will now be extended over a further 12 months."



"However, the additional time and cost to develop Lorenzo is expected to be supported by monthly revenue receipts during the development period."



The Lorenzo project, under the National Program for IT, is being carried out by the British National Health Service. Cohen has repeatedly said political changes in the country are responsible for the delays.



And while revenue continues to take a beating, it is understood the company is having to shed hundreds of staff. The Australian Financial Review has reported 600 jobs have been shed, with another 500 to come by the end of the year as part of a massive cost-cutting exercise.

The announcement also comes a week after the company acquired a $30 million line of credit from YA Global, a US investment fund. BlackRock Investment Management also bought more stock yesterday, and now holds a 5% stake in the group.



Cohen was contacted for comment by SmartCompany, but no reply was received before publication.



The announcement only fuels speculation private equity firms are eyeing the company. Investment groups including HgCapital, Duke Street Capital and General Atlantic have been named as possible buyers, while 26% stakeholder Oceania Capital Partners has also been named.



Despite the company's protests the downgrades are purely due to the British election upheaval, analysts say management is the problem – specifically Cohen's style. Last month, BBY analyst Mark McDonnell downgraded iSoft from a "buy" rating to "underperform" due to Cohen's management.



"The management weaknesses are most apparent in relation to its inability to provide reliable short-term forecasts of business performance, compounded by its habit of continually blaming factors 'beyond the control' of the company for its business reversals, (whether they have currency movements, project delays or foreign elections)."







  Forum: By Share Code

bing
Posted on: Jul 9 2010, 03:21 PM


Group: Member
Posts: 304

From Sydney Morning Herald - Business Day page 9 - Friday 9th July 2010

Insider article by David Symons.



SOFT TOUCH

Another Australian company doing battle with soft economic conditions in the Britain has struggled to respond to a fresh batch of questioning this week. Healthcare software developer iSoft is attracting attention for a $30 million equity line of credit facility sourced from the US hedge fund YA Global.

The facility allows iSoft to issue shares any time in the next 60 months in tranches of up to $2.5 million.

So far, so good. But facilities of this type have brought plenty of companies unstuck. iSoft shares are already down more than 70 percent for the month after announcing a massive downgrade, and if it turns out that YA Global doesn't have long-term investment intentions, selling by the hedge fund could send the shares sinking further.

Not helping perceptions is YA Global track record.

Locally, efforts to extract full value from an investment in Compass Resources saw YA Global team up with the Compass chairman, Gordon Toll. They asked shareholders to approve a proposal that $70-odd million of debt be converted into a 95 per cent stake in the explorer, once valued at more than $700 million.

Internationally, YA Global has attracted attention for initiatives including a failed attempt to push into liquidation the US biotech Cobalis, in which it held some convertible notes.

Not that any of this concerns iSoft's chief, Gary Cohen. Responding to questions about the facility, he was quick to differentiate YA Global's equity line of credit offering from its convertible note structures.

Indeed, according to Cohen, large Australian companies including "Fortescue Metals and the Australian Gaslight Company" have previously called on the services of YA Global.

Apparently not. A spokesman for AGL yesterday noted that nobody currently working in the company's head office had any recollection of AGL ever having an association with YA Global.



  Forum: By Share Code

bing
Posted on: Jul 5 2010, 02:56 PM


Group: Member
Posts: 304

From the FinRev a couple of days ago -

At the other end of the market, iSOFT and Elders are the worst performing stocks, down 69.03 per cent and 64.22 per cent this month.
iSOFT's shares plummeted earlier in the month after it cut its profit forecast for financial 2010 to between $45 million and $60 million from a previous guidance of $106 million.
Elders is potentially facing legal action after it shocked investors last week, warning it would make a loss of up to $14 million just a month after saying it would post a $48 million profit.
iSOFT and Elders have faced additional selling pressure as investors have dumped underperformers ahead of the end of the financial year to minimise capital gains.
  Forum: By Share Code

bing
Posted on: Jun 13 2010, 09:30 PM


Group: Member
Posts: 304

How do I add a linked chequeing account to an existing investment account?

Add a linked chequing account to an existing investment account


1. Choose Tools menu > Accounts List.
2. Select the investment account to which you'd like to add a linked chequing account, and then click Edit.
3. If necessary, click the General Information tab.
4. For the Show cash in a chequing account option, select Yes.
5. Quicken prompts you to back up your data file. After the backup is completed, Quicken creates the linked chequing account with the same name as your investment account, plus the suffix Cash.

Click OK to close the Account Details dialogue and save your changes.

----------------------------------------------------------------------

I have done this and now whenever I do a trade it shows the Linked Cash account in the window under
"Use Cash for this Transaction"

Good luck!

Bing
  Forum: Off Topic Chat

bing
Posted on: Jun 9 2010, 04:11 PM


Group: Member
Posts: 304

25c gone!!! WOW

when will the ASX give iSoft a downward velocity ticket?

May be I should call them and ask why we don't see any action on their part.

And why don't we hear anything from the company to give more information
and to give assurances in order to stop this crazy sell off.
  Forum: By Share Code

bing
Posted on: Jun 8 2010, 01:39 PM


Group: Member
Posts: 304

30c gone !

When 'o' when will we see the bottom of this sell off.

Why does this have such a devastating effect, a profit downgrade in these times is not uncommon.

But what is uncommon is the drop in the iSoft share price of 28c or 48.69% since
31st May 2010.

So there must be more to it.

What is it we don't know?
  Forum: By Share Code

bing
Posted on: Jun 2 2010, 08:36 PM


Group: Member
Posts: 304

Bloomberg reports on the 30% fall today.


http://www.businessweek.com/news/2010-06-02/isoft-shares-fall-record-30-blames-u-k-election-update2-.html

What next?

Bing
  Forum: By Share Code

bing
Posted on: Jan 14 2010, 08:00 AM


Group: Member
Posts: 304

sorry try again!


Lincoln Indicator's CEO

Elio D'Amato's top 10 best stocks to buy in January 2010

2nd on the list is Cellestis!

Let's see what happens from here.
  Forum: By Share Code

bing
Posted on: Jan 14 2010, 07:58 AM


Group: Member
Posts: 304

<h1 style="margin: 0px; font-weight: normal; font-size: 12pt; color: rgb(0, 0, 0);">Lincoln Indicator's CEO
</h1><h1 style="margin: 0px; font-weight: normal; font-size: 12pt; color: rgb(0, 0, 0);">
</h1><h1 style="margin: 0px; font-weight: normal; font-size: 12pt; color: rgb(0, 0, 0);">Elio D'Amato's top 10 best stocks to buy in January 2010</h1><h1 style="margin: 0px; font-weight: normal; font-size: 12pt; color: rgb(0, 0, 0);">
</h1>
2nd on the list is Cellestis.

So let's see what happens from here!
  Forum: By Share Code

bing
Posted on: Dec 28 2009, 04:50 PM


Group: Member
Posts: 304

First Case of Drug-Resitant TB Found in the US!!


http://www.time.com/time/health/article/0,8599,1950169,00.html
  Forum: By Share Code

bing
Posted on: Oct 13 2009, 09:04 PM


Group: Member
Posts: 304

From the IT section of The Australian newspaper


A healthy start on e-records


The world according to Peter Fleming | October 13, 2009


IT is about a year since Peter Fleming became Australia's e-health boss with a mandate from the nation's health ministers to speed up electronic reform of the notoriously fragmented health sector, and enable doctors to securely send and receive patient health information.

Set up in 2004 as a not-for-profit company, the National E-Health Transition Authority is developing the technical standards and regulatory frameworks to underpin the widespread adoption of e-health systems.

Fleming's experience in large technology projects in retail, banking and pharmaceuticals was seen as a welcome balance to the organisation's earlier academic focus, and he has been out talking to doctors, software developers and consumers ahead of a shift towards delivery.

Now that you have released NEHTA's strategic plan for the next three years, what happens from here?

First, the strategic plan should not take anyone by surprise. It's really just enunciating things we've been talking about for a while.

It's still fairly high-level, I accept that, but we're trying to follow a process and avoid confusing people. While we will publish the detail, we want to articulate the big-picture stuff first, so that when people do look at the detail it's in context.

The overall plan obviously will be influenced by feedback from stakeholders but I'm expecting to present that to the NEHTA board when it meets on the October 27.

We have been doing quite detailed work on the business and technical architectures, talking to the software people about the technical issues and helping clinicians understand the business architecture and process issues.

As part of defining the strategy for each of our audiences, we're producing a series of documents that puts things in context for a general practitioner or a consumer representative.

It's an iterative process and clearly that dialogue is starting with the peak bodies.

Phase one is already well under way. I was working through a draft of the business architecture last week, and we're ready to take it to stakeholders for feedback.

I can't give you a date for its public release, but I expect it will be this year.

I saw a draft of the GP document late last week. There's a lot more work to be done there but it should be released within the next two months.

The other aspects involve the more detailed timelines you'd expect to see for each of our main projects, as well as who is responsible for doing what. Clearly that also has to be linked into planning by each of the jurisdictions.

Much of NEHTA's program to date has been based on the needs of the public sector. Consumer groups have expressed frustrations over being left out of the process. How are you addressing that, and involving those in the primary care, aged care and private sectors?

There's never going to be a perfect system. There are 850,000 people working in healthcare and they are represented by any number of bodies.

But we created the Stakeholder Reference Forum to include all the key groups, and we have regular meetings with that forum, as well as individually with the members.

The forum has formed six sub-committees based on our key projects, and the people involved really do have a very strong say in terms of the requirements, the specifications, the ongoing testing and process implications.

Under Mukesh Haikerwal, the clinical leads team has been expanded to include all of the future users of e-health systems, not just GPs but specialists and allied health professionals as well.

We recognise that this process needs to be inclusive: the technology is just the tip of the iceberg and we've got to get all these other things right if we're to be successful.

Federal Health Minister Nicola Roxon has indicated personal e-health records offered by providers such as Google and Microsoft could be a quick way to give patients access and control over their own health information. Would this be useful, and how would you ensure availability and confidentiality over a range of commercial products?

The key here is what architecture we will end up with for an e-health record, and there has only been minimal work on that front because the Council of Australian Governments has not yet approved the business case for electronic health records.

From the discussions we've been having, though, a number of scenarios could play out.

Initially I would expect a number of e-health records in the market, and the role of government in that context would be to ensure standards and privacy rules are all met, but it will probably be necessary to build an indexing service, as a person's records will likely be scattered across various providers.

So the indexing service would firstly say where the records are located. For example, an MRI scan may be held at the location where the image was taken.

We also think a summary health profile should be attached to that indexing service, so that if you are rushed into an emergency department in the Northern Territory the summary will provide everything a physician needs to know, such as medications or allergies.

That would be held centrally, not a huge database but just the key information required in an emergency.

Once, and if, COAG gives a tick on e-health records, we will engage widely in terms of the architecture, but I think that's the reality we'll see.

Are you getting pressure from IT vendors to just get on with it?

Interestingly, it's predominantly the larger vendors offering health records at the moment, but we're seeing a lot of dialogue between potential consortiums looking at how they would bring this together.

Those parties are trying to get a sense of how we think the standards will develop over time. I wouldn't define it as pressure, it's a constructive dialogue.

While the work with Medicare on healthcare identifiers is complete, it's still unclear whether the enabling legislation will be passed by next July, as planned. What happens if there is a delay?

Well, we can take advantage of the fact the systems are built and begin testing with industry and the health community to ensure the processes are right.

Ideally, we'd like to see the legislation in place by middle of next year, but all sorts of things can happen to move that forward or backwards that we can't control.

We'll continue down the development path. For instance, we're working with Medicare on a group of projects that start linking with and using identifiers, such as discharge referrals.

As soon as the legislation is enacted, we'll be ready to run with it.

One area where the industry has definitely got ahead of your work and the government's thinking is electronic prescribing, where we are seeing a land grab by two very determined players - MediSecure, backed by the Royal Australian College of General Practitioners, and eRx supported by the Pharmacy Guild. Are you reasonably optimistic that the two systems can be made to work together?

Oh, I believe so, one way or another. Next week I am sitting down with the chief executives of those organisations (to discuss) our very strong view on the need for open and interoperable systems.

Both groups have committed to go down that path at the initial discussions I've had with them, and both understand that there has to be a sharing.

Now, it's early days, and we'll need to work through that.

If we can make this work, it's absolutely brilliant. We've got two competitors out there building these systems, and potentially there will be others down the track.

So, e-prescribing is happening, it's something we don't have to go out and build; this is the sort of things we want to encourage - providing it's done to standards, the systems are interoperable and the data is being shared effectively, and the privacy components are being met.

That means software certification and accreditation processes, and you have suggested this could be done through existing facilities such as Australia's National Association of Testing Authorities (NATA). Does accreditation advantage larger firms, and how can we retain local players in an international marketplace?

Look, I hope there are any number of ways of ensuring we retain local players.

We need those small, innovative organisations that bring to light things we may not have thought about, or things larger companies haven't been able to drive through.

In terms of certification and accreditation, we've started that dialogue.

This is not necessarily something we would build internally.

Clearly the medical software industry is a key participant, while as a clinician you want to know that what you buy is fit for purpose.

We also have to consider the cost and the infrastructure required, so we are looking at existing groups, such as NATA, and how we can leverage them going forward.

We need to understand the divergence of opinions within the industry, so input from the Medical

Software Industry Association is a good starting point.

And there won't be one solution that makes everyone happy, I know that, but we'll work through the issues.
  Forum: By Share Code

bing
Posted on: Oct 13 2009, 09:02 PM


Group: Member
Posts: 304

From IT section of The Australian newspaper

Governments change direction on health e-records


Karen Dearne | October 13, 2009

GOOGLE, Microsoft and other new providers will host Australians' electronic health records as the federal and state governments back away from funding a nationwide scheme.

National E-Health Transition Authority chief executive Peter Fleming said the original vision of a single e-health record system had been abandoned in favour of "person-controlled" records that could be adopted more quickly.

The Council of Australian Governments is yet to make a decision on the business case for individual e-health records put to it by NEHTA a year ago, but Mr Fleming said the health ministers were pushing the organisation to take "a far more commercial approach".

"Five years ago, there was a strong view that there would be an e-health record for all Australians held on a massive database somewhere," he told the Medical Software Industry Association conference in Sydney last week. "That's no longer the view.

"When and if the e-health record is approved, we'll enter into detailed planning around the architecture, but undoubtedly people will have an option to choose health records from a range of sources and their medical information will be stored in a number of locations."

Mr Fleming said the foundation work on healthcare identifiers, secure messaging and other technical standards would support a rollout of personal health records by 2012, although a new indexing service would be needed to bring disparate files together at the point of care.

To cater for emergency situations, a health summary containing key medication and allergy data could be linked to the index. "Certainly there needs to be a viable financial model for the private sector, in terms of margins or incentives, but I would see those things occurring," Mr Fleming said.

"One of our directions now is how we engage the private sector and move these things forward."

NEHTA has released to public discussion its strategic plan for the next three years to 2012.

Mr Fleming said Medicare would complete its construction of the Unique Healthcare Identifier service, which will assign and manage identity numbers for patients, medical providers and healthcare venues in December.

The system could not, however, be launched until new legislation amending the federal Privacy Act was passed by parliament, he said. Meanwhile, software vendors will have access to a model environment running dummy data for testing purposes. While the use of patient identifiers may be optional initially, Mr Fleming said, over time "we expect this to become ubiquitous".

Meanwhile, the Australian Privacy Foundation has slammed NEHTA for shutting consumers out of the e-health consultation process.

APF health spokeswoman Juanita Fernando said the strategic plan positioned consumers as "targets" for public marketing campaigns -- rather than as key participants in the development process -- despite NEHTA's "assertions" of inclusion.

"Why does the bulk of NEHTA's plan focus on stakeholders rather than consumers?" she said. "Why does NEHTA so tightly control feedback that ordinary consumers are not invited to attend various consultations?"
  Forum: By Share Code

bing
Posted on: Sep 28 2009, 10:02 PM


Group: Member
Posts: 304

More to my earlier post!

Article which appeared in Business Day on Wednesday 23rd September 2009.

Quote
Dell buys in to stimulus pie.

By Saul Hansell and Ashlee Vance

Dell, which has struggled with flagging sales of personal computers and severs during the downturn,
has bought itself a piece of the US Government's stimulus pie.
The company said it would spend $US3.9 billion($4.5 billion) in cash to buy Perot Systems, a provider of technology
services that is especially strong in the growing field of electronic health records. The Government is pouring
$US19 billion over the next five years into technology to help doctors and hospitals digitise medical records.

Dell and Perot were already working together on some medical projects, but the combination brings tremendous firepower to the task.
Perot serves 1000 hospitals - more, it says, than any other services firm. Perot helps to automate the patient records of 200,000 doctors

While Dell has long taken a lean and focussed approach to the computer business, devoting itself mainly to wringing
the most efficiencies possible out of manufacturing process, it has been forced to look for new ideas in recent years.

The recession has hit Dell hard because it depends more than its rivals on sales to businesses, which have frozen
their purchases of PCs and other data centre equipment.

Dell's largest rivals - IBM and Hewlett-Packard - are leading players in computer services, which provide a steady
revenue stream that is less vulnerable to the fluctuations of the economy.

Dell is paying $30 a share for Perot Systems, a 61 per cent premium over the closing price last week.

A.M.Sacconaghi, a computer hardware analyst at Stanford Bernstein, said Dell paid "a rich price" but the deal was ultimately sound.

The New York Times

unquote.

  Forum: By Share Code

bing
Posted on: Sep 11 2009, 12:06 PM


Group: Member
Posts: 304

Some more competition in the US!

Dell said its technology to digitise medical records for physicians working with hospitals is less expensive
and more compatible with outside systems, hurdles that have held back the movement to put records online.

Dell closed up 64 cents (4%0 at $16.56


http://money.cnn.com/news/newsfeeds/articl...84_FORTUNE5.htm

  Forum: By Share Code

bing
Posted on: Jul 30 2009, 02:23 PM


Group: Member
Posts: 304

Sorry should read

www.manlydaily.com.au
  Forum: By Share Code

bing
Posted on: Jul 30 2009, 02:22 PM


Group: Member
Posts: 304

Extract from the Manly Daily yesterday - Article by Bill Harcourt - weekly Finance columnist
www.manydaily.com.au

For those who don't know , this local paper gets house delivered to
householders on the Northern Beaches Sydney.

Quote
Silex a unique Australian company, orginally out of nuclear energy facility at Lucas Height,
is more than half green because not only does it have a new uranium enrichment
technology, now classified as secret by the Australian and US Governments, it is also
involved in solar energy having recently bought all the manufacturing assets and equipment
of the Sydney Olympic Park Solar manufacturing operation from BP for $6.5 million.

Olympic Park Solar is the largest solar manufacturing facility in the Southern Hemisphere
with more than 50 MMW (MegaWatts) of solar cell production and 10 MMW of module
production annually.

Silex has a patented Translucent Solar Cell technology that it claims will increase solar
conversion efficiency, lowering the cost per watt of electricity produced.
Unquote

Who knows but this may generate some buying interest of Mum & Dad investors!
  Forum: By Share Code

bing
Posted on: May 10 2009, 09:57 PM


Group: Member
Posts: 304

Weekend Finrev page 16 section IN BRIEF



CAPE LAMBERT BID WINS


by Luke Forrestal



Cape Lambert Iron Ore has been named the successful bidder for the assets of failed miner CopperCo


that include the Lady Annie copper mine in northern Queensland. Cape Lambert spent more


than $100 million acquiring CopperCo’s secured debt in February and has agreed to pay


an additional $27 million to take assets out of receivership.







  Forum: By Share Code

bing
Posted on: Apr 1 2009, 03:44 PM


Group: Member
Posts: 304

Considering the Rudd government looks up to the Obama team it could well be repeated here that more money will be
sepnd on e-health.

IBA Health is in a very good position to benefit from this and further deals in Asia and other overseas markets could be happening
when they see that Australia wide e-health is implemented.

I have taken up my entitlement and I don't expect the share price to dip below 55c.

The entitlement is such that shareholders are only allowed to take up 2 for every 7 shares held, which indicates to me that there is a cap in place and is underwritten by ABN AMRO who I am sure would not have entered in such a deal if they were not sure this would be a good offer.

More over the financial crises doesn't seem to have much impact on the results of the company. Revenue comes mainly from government bodies and more sales have been happening.
  Forum: By Share Code

bing
Posted on: Mar 31 2009, 07:37 PM


Group: Member
Posts: 304

Interesting article appeared in the Information section of the Finrev today on page 31, called



"Urgent call for health records" by Ben Woodhead and Brian Corrigan.



Took me a while to copy this article but I think it's worth reading. IBA Health gets a good mention. Must be good for pushing the SP up.



The article talks about the implementation of electronic health records(EHR) in Australia.

-------------------------------------------------------------------------------------------




Health-care professionals and technology developers are pressing the federal government to use economic stimulus funds to implement EHR. Executives from organisations including the Australian Medical Association, hospital software developers, multinationals IT firms and small business have joined the call. At stake they say, is a project that would spur employment and export opportunities while introducing a potentially life-saving medical records system for Australian residents.



The push to re-invigorate efforts to create a national EHR has gained fresh momentum after US President Barack Obama announced he would provide $US19 billion for e-health under his economic stimulus package. AMA federal president Rosanna Capolingua describes the Obama plan as a very sensible use of stimulus funding, and urges the Rudd government to take similar action.

"Not only would this create jobs and infrastructure now, but it would also deliver an e-health record that's important for the future of Australians," Capolingua argues. “We have been concerned that the last two stimulus packages didn't put any money towards health. When you put money into health, you reap the returns over time."



IBA Health chief executive officer Gary Cohen agrees. IBA is Australia's largest software company with 4,000 employees worldwide. Most staff are based offshore, working on projects such as the British public hospital sector's £12 billion ($24.8 billion) National Program for IT. Cohen says e-health decision making in Australia is too fragmented and that a federal government commitment to a similar, countrywide EHR would enable IBA to boost headcount here.



"I think when you are dealing with the sort of financial crises that have beset a lot of the health sector across Australia, you don't end up with a lot of planned business decisions going on" Cohen says. "If you look at the Obama package they are spending $30 billion on the computerisation of health records over the next few years, the UK's spending $30 billion on its population and Australia has allocated a couple hundred million to help NEHTA out ." NEHTA, the National E-Health Transition Authority, re-iterated its hopes for a full federal backing this year of a national individual EHR for Australian residents.

Cohen says it is possible to create such a system in the next several years with as little as $2 billion. Australia spent $94 billion on health care in fiscal 2007. It is argued that a national EHR would allow the redeployment of hundreds of millions of dollars of that money each year while potentially saving thousands of lives.

The federal governemt has already commissioned Deloitte Touche Tohmatsu to produce a national e-health strategy for the creation electronic health records for all Australian residents.

According to a summary of the document released in December, governments across the country have pumped as much as $5 billion into EHR initiatives over the past 10 years, but have made little progress towards creating a national system.

The government is yet to release the full e-health strategy, but the summary shows that Deloitte advised authorities to embark on a co-ordinated, national approach to EHRs that would eliminate duplication in health records.

Deloitte technology partner Adam Powick says that e-health experiences in Canada suggests Australia could create between 20,000 and 30,000 high-value jobs in the near term if it moved in a co-ordinated fashion to create a national EHR.

"There are two aspects to that. One is that there is a quite significant amount of pent-up innovation in this country that needs a stake in the ground and the right incentives," Powick explains.

"We also have an opportunity to absolutely be seen as leaders in Asia in terms of the development of specific technology solutions in fields such as decision support, telehealth, remote monitoring, electronic prescriptions and electronic test ordering."

Advances in those areas would develop export opportunities for small and large technology developers, he says.

Multinationals that have stated an interest in the national implementation of individual electronic health records include IBM and Microsoft. Myriad small, local health technology developers are also lobbying hard for a national EHR program.

One is Ballarat-based VIACOE RDF. VIACOE chairman Peter Moon, who also runs small Victorian communications outfit HORIZON Broadband Communications, says he has already petitioned Deputy Prime Minister Julia Gillard Innovation Minister Kim Carr and Infrastructure Minister Anthony Albanese on the issue.

He says the federal government needs to step in and mandate a national EHR program to avoid the problems that affected the Howard government’s troubled Healthconnect e-health initiative.

Moon adds that economic stimulus activities could give Australia the ability to create jobs and export opportunities through e-health. "If you don't have [a federal mandate], the states are going to want to run EHRs themselves because they can all be parochial. HealthConnect didn't work because it didn't really have buy-in from the states."

Moon adds that the government needs to consider the role of small and medium-sized businesses in any national EHR project if it wants to maximise its economic benefits.

He says that even if the government opted to use large companies as prime contractors to deliver a national system, it should require a local industry component in any contracts it awarded.



  Forum: By Share Code

bing
Posted on: Mar 20 2009, 04:28 PM


Group: Member
Posts: 304

I think insto's had to buy IBA now that it is included in the ASX200 index.

Received the Limited Equity Raising form today and shall buy my full entitlement at 55c/share.

A great little capital gain to look forward to.
  Forum: By Share Code

bing
Posted on: Mar 16 2009, 09:17 PM


Group: Member
Posts: 304

This article appeared in the Finrev on Monday 16th March 2009

"ASIC worried over margin loan disclosure" by Patrick Durkin.

Key points: There is concern that some directors are still resisting disclosure
ASIC wants civil penalties introduced for rumourtrage.
A risk of misinterpretation remains.


In its submission to the government-backed review on the integrity of the stockmarket, ASIC said
directors entering into margin loans created potential conflicts of interest and that disclosure of
margin loans to the board should be mandatory, with the ASX Corporate Governance Council developing
principles to guide company policies on the issue.

ASIC also wants civil penalties introduced for rumourtrage - the spreading of false, negative rumours
about companies - in addition to existing criminal penalties, to provide "access to the full range of
regulatory options" and ensure rumourtrage is "met by a scalable response".

The regulator also said recording of all stockbrokers' calls in combination with prohibiting mobile
phones on the trading floor, would help deter rumourtrage. But whether the cost outweighed the
benefit was a matter for the government, it said.
Chartered Secretaries Australia backs to ASIC call, saying directors said should be forced to
disclose margin loans if they have borrowed against more than 5 per cent of their company's shares.

The call for reform comes after the exposure of directors' margin loans at companies including ABC
LearningCentres, Allco, Centro and MFS last year caused their share price to tumble, precipitating
their collapses.
"When the market observes a director selling shares, even when it is a forced sale, the market may
perceive such a sale as representing in side knowledge of the prospects and performance of the
company," CSA chief executive Tim Sheehy said.

"There is a serious risk of misinterpretation by the market that directors are seeking to exit their
investment, if investors do not know that a third-party right exists in the shares.

The Australian Shareholders Association called for directors to be banned from trading in blackout
periods - the two months before a company's profit result, earnings upgrade or takeover announcement.
The current regime, which leaves it to the companies to set their own policy, created uncertainty,
lacked transparency and did not prevent directors from engaging in insider trading, the ASA said.

Recent research by the Australian Securities Exchange found more than 50 per cent of all directors
share trades occurred during blackouts, and of those, more than 13 per cent potentially contravened
company trading policies.

"Retail shareholders have long been concerned [about] insider trading by directors and executives,"
the ASA said in its submission to the government's corporate law adviser, the Corporations and
Markets Advisory Committee. "[The data] has left the association increasingly concerned that the
current laws do not act as a sufficient deterrent to insider trading".

The ASA says a blanket prohibition should apply to directors trading in blackouts in addition to
existing laws on insider trading, with a power for ASIC to approve exceptions in the case of
financial hardship.
  Forum: By Share Code

bing
Posted on: Mar 16 2009, 08:30 PM


Group: Member
Posts: 304

Posted this a while ago on another SS thread and think it is useful to post here too.

Like to know if the buy and sell orders come from one source/computer, which we know is not allowed.

Here it is
----------------------------------------------------------------------

Received this reply from the ASX when I questioned whether the very low volume trades of Cellestis
shares was manipulation or not.


Quote

04 March 2009
RE: Market Manipulation in CST.
Thank you for this information regarding CST in respect of possible Market Manipulation. ASX Ltd
appreciates information that is gathered from the public as it assists us in our role of maintaining
market integrity by requiring compliance with the obligations set out in the ASX Operating Rules.

Having reviewed the course of sales data for CST for recent days it appears the trades you are referring to,
are the result of DMA (Direct Market Access) or algorithmic trading.

You may be aware that DMA trading allows a client to send orders directly onto a trading platform without
human intervention. One form of DMA trading involves a strategy where a single order might be split up into
several smaller orders which are submitted periodically (every 3 minutes for example).

This type of DMA trading is normally unremarkable and has no impact on the price or volume of a stock. However,
occasionally market observers may see small volume orders being submitted to a trading platform in a less liquid stock
which result in small volume trades.

Surveillance monitors DMA trading and expects brokers to have in place appropriate mechanisms to ensure that such
trading is not manipulative. DMA trading is an increasingly popular means of trading, particularly when a participant
seeks to track VWAP or ‘slice and dice’ an order for other purposes. Further details and articles regarding DMA trading
can be found be searching under "DMA Trading" on the ASX website.

Please refer to this link for more information on the ASX Market Surveillance function:
http://www.asx.com.au/supervision/particip...urveillance.htm

Thank you once again for raising your concerns with ASX.

Yours sincerely,
Sai Sridhar
Customer Service
Australian Securities Exchange

Unquote
  Forum: By Share Code

bing
Posted on: Mar 10 2009, 01:09 PM


Group: Member
Posts: 304

In today's Finrev page 25, IBA is reported to be included in the ASX200 on March 20.

What impact this may have on the share price is unknown at this stage.

Small-cap index fund managers reportedly may have to sell but then others may have
to buy to include new members of the ASX200 club.
  Forum: By Share Code

bing
Posted on: Mar 10 2009, 08:10 AM


Group: Member
Posts: 304

CELLESTIS - STAR STOCK !!!!!!!!!!!!!!!!!!!!!!!!

A friend told me that Cellestis is now regarded as a Star Stock with Lincoln Stock Doctor.

He gave me this Company Summary Table whicl lists all the financial details of this stock.

This is a significant change as Lincoln Indicators has a good name and is highly regarded amongst investors and institutions.

I have attached the summary as a jpg file.

Hope you do not have difficulty downloading the file, otherwise let me know and I'll email.


Attached thumbnail(s)
Attached Image


 
  Forum: By Share Code

bing
Posted on: Mar 7 2009, 08:00 PM


Group: Member
Posts: 304



Received this reply from the ASX when I questioned whether the very low volume trades of Cellestis
shares was manipulation or not.


Quote

04 March 2009
RE: Market Manipulation in CST.
Thank you for this information regarding CST in respect of possible Market Manipulation. ASX Ltd
appreciates information that is gathered from the public as it assists us in our role of maintaining
market integrity by requiring compliance with the obligations set out in the ASX Operating Rules.

Having reviewed the course of sales data for CST for recent days it appears the trades you are referring to,
are the result of DMA (Direct Market Access) or algorithmic trading.

You may be aware that DMA trading allows a client to send orders directly onto a trading platform without
human intervention. One form of DMA trading involves a strategy where a single order might be split up into
several smaller orders which are submitted periodically (every 3 minutes for example).

This type of DMA trading is normally unremarkable and has no impact on the price or volume of a stock. However,
occasionally market observers may see small volume orders being submitted to a trading platform in a less liquid stock
which result in small volume trades.

Surveillance monitors DMA trading and expects brokers to have in place appropriate mechanisms to ensure that such
trading is not manipulative. DMA trading is an increasingly popular means of trading, particularly when a participant
seeks to track VWAP or ‘slice and dice’ an order for other purposes. Further details and articles regarding DMA trading
can be found be searching under "DMA Trading" on the ASX website.

Please refer to this link for more information on the ASX Market Surveillance function:
http://www.asx.com.au/supervision/particip...urveillance.htm

Thank you once again for raising your concerns with ASX.

Yours sincerely,
Sai Sridhar
Customer Service
Australian Securities Exchange

Unquote





  Forum: By Share Code

bing
Posted on: Mar 2 2009, 09:08 PM


Group: Member
Posts: 304

This article which appeared in BBC UK talks about new drugs for MDR - TB

Interesting to read and aslo the "See Also" links on the righthand side.

http://news.bbc.co.uk/2/hi/health/7913190.stm

such as this one

Rapid Test for Drug Resitant TB

http://news.bbc.co.uk/2/hi/health/7481199.stm

Drug resitant TB on the rise in the UK

http://news.bbc.co.uk/2/hi/health/7379500.stm
  Forum: By Share Code

bing
Posted on: Feb 15 2009, 03:08 PM


Group: Member
Posts: 304

This article appeared in "Wealth" section of The Australian newspaper on Wednesday 11th February 2009.
In the Small-cap Spotlight, page 5.

Company : Arana Therapeutics Limited (AAH)
Share Price: 86c
Market Cap : $190 million
Recommendation: Speculative Buy

The biotechnology sector is known for a high cash burn rate and long periods between announcements, as companies take time to research and conduct trials on the products they have created in the lab.

News about positive trial outcomes is usually the share price driver, as companies seek regulatory approval to sell their goods.

Despite these lengthy developmental and testing periods, a biotech company that successfully commercialises a product with the potential for widespread use can be worth the wait. Unlike other sectors, income in the health technology space can be resistant to economic cycles. Future revenue prospects instead rely on current funding and developmental progress, which is why health technology has been one of the few sectors to feature regular outperformers over the past six months.

Wise-Owl.com analyst Josh Terlich would not be surprised if Arana Therapeutics were to join the small list of stocks swimming against the tide in coming months. Focused on the fast-growing antibody therapeutics sector, Arana aims to commercialise treatments for inflammatory illnesses such as rheumatoid arthritis and cancer. With ample funding and key developmental milestones approaching, Terlich highlights the stock as an attractive speculative opportunity in the sector.

"Arana already generates revenue ($39.5 million in 2007-08) through royalties and other services income, but its developmental pipeline is targeting the U$20 billion ($30.8 billion) therapeutic antibodies market," he says.
"Being debt-free, holding $180 milllion cash, and expecting a further $68-$75 million in royalties through to early 2011, funding looks stable for some time yet.

At the moment, Arana is focused on the development of an anti-inflammatory medication known as ATR621, designed to relieve the symptoms of psoriasis and rheumatoid arthritis.

ATR621 leads the internal clinical pipeline and is undergoing phase II trial, with results due in the first quarter of this year.

Should the phase II trial reports for ATR621 be positive, Terlich says, the news could generate strong interest in the stock.

"Successful phase II results would be a key share price driver. Furthermore, with cash levels equating to 78c a share, very little value is being ascribed to Arana's clinical pipeline, creating an attractive risk-to-reward proposition for investors in the stock."
----------------------------------------------------------------------------------------------------------------------------------------------




Worthwhile article I reckon!
  Forum: By Share Code

bing
Posted on: Jan 30 2009, 05:27 PM


Group: Member
Posts: 304

Hi All,

A broker I was talking to mentioned in passing that Cellestis was involved in a court case in Britain about a patent infringement.

He didn't divulge further information and I can only think that he must have seen it on Bloomberg or so.

Sorry if I have started something which may not have occurred recently.

Perhaps we can check with Cellestis Management.
  Forum: By Share Code

bing
Posted on: Jan 30 2009, 01:00 PM


Group: Member
Posts: 304

Apparently Cellestis is suing this company for patent infringement.
  Forum: By Share Code

bing
Posted on: Jan 30 2009, 12:35 PM


Group: Member
Posts: 304

I hear on the grapevine that Cellestis is in court in Britain about a patent case.!!

Does anyone have more information.
  Forum: By Share Code

bing
Posted on: Jan 29 2009, 06:35 PM


Group: Member
Posts: 304

BM

One possible explanation I can think of is that forced sales are causing this sell down.

Who else in his sane mind would sell at such ridiculously low prices!

Margin lenders may take hold of investors stocks and sell them if they cannot get
them to inject cash after a margin call.

This then becomes self serving as more and more investors get margin calls when
share prices keeps on dropping.

Don't forget also that this is an illiquid stock yet the increased volume
of shares traded these days are an indication that large parcels are pushed through.

What we are seeing is a buyers market which is able to force the price down more and more.

This will only end when there is more demand for this stock.
  Forum: By Share Code

bing
Posted on: Nov 30 2008, 08:07 PM


Group: Member
Posts: 304

In reply to: forrestgump on Saturday 29/11/08 08:41am


Hi Forrest and others,


First I dislike the fact that replies to my posts contain personal advice as to what I should or should not do. If I need investment advice I may decide to consult a financial planner. Then also Sharescene is a forum for investors to discuss stocks but this thread covers far more the product than the actual performance of the share price.

We should be able to discuss objectively the relative performance of of the stock and its share price. This is what stock analysts do, comparing a stock against a range of measures in an objective manner without any emotional attachment to the stock. I think we have to be honest with ourselves and be prepared to look at the hard cold facts and not justify adverse occurrences with excuses.

In comparison with other stocks in similar situation as Cellestis, it is strange to say the least that the share price goes south when the financial performance of the company gets better and better. Any other stock would attract increased investor attention in such a situation and a higher demand would translate in a higher share price.

We can come up with all sorts of reasons why it is going south instead of north, but the fact is there and I am trying to unravel WHY this is so. This is what I like to discuss with like-minded people in a civil way without resorting to condescending advice. (by the way this is against the charter of Sharescene)

Don't get me wrong, I am also convinced that Cellestis has a superior product and is now showing a profitable result which no doubt will improve quarter by quarter. It's just not evident in the share price. If good results and no debts do not translate in a higher share price, what will?

We differ about the fact that management should be worried about a falling share price and that they should do their utmost to rectify this. Many investors and analysts think that there is something wrong with the way the company is managed.

This is a quote from Matt Comyn's article!
Another pertinent reason is that a falling share price can impact on the reputation of a company, and therefore reflect on its management. If the share price of a company continually underperforms the overall market, shareholders are going to look for someone to blame.
Unquote

I wonder whether the Cellestis Board accepts that a falling share price says something about the way the company is managed.

  Forum: By Share Code

bing
Posted on: Nov 28 2008, 04:23 PM


Group: Member
Posts: 304

In reply to: GuppyTrader on Friday 28/11/08 04:48pm


GT,

Good to see the slide was shown at the AGM.

The issue we are concerned about is that the share price has not been in decline just in 2008 but has a history of continuously going south since March 2006.

There are stocks which even in 2008 have held up quite well due to good results and Cellestis with their excellent results could have done the same.





  Forum: By Share Code

bing
Posted on: Nov 28 2008, 02:42 PM


Group: Member
Posts: 304


Forrest,

This is what I specifically expect from management.

1. That they recognize that the company is owned by shareholders and that they can't run this as a private company.

2. That they have an obligation to look after the monetary interests of shareholders. They are shareholders to make a buck, not just to provide the scientists with a means to satisfy their own personal interest in scientific work.

3. That it is expected of management of a public company to maintain or improve shareholder value. This not only involves running the company with a profitable result but also consider what can be done to give shareholders a return on their investment.

4. To show that there is possibly no concern amongst the board of directors about the falling share price is that no mention was made about it at the AGM.
Not one post on SS about the AGM said anything about a discussion of the falling share price!

5. The directors should worry that the stock is an illiquid one and prone to mistreatment by bot traders and the like. Has anything been mentioned about the illiquid state?

6. In order to create some investor interest in the company and not to cause a spike in the share price but sufficient interest to create a stock which is liquid and therefore less likely to be manipulated. What the directors should do is invite the financial press and institutions to show and explain their excellent results.
This may create interest amongst investors. If a survey was done amongst investors now, I wonder how many know or have heard of Cellestis!
It is the duty of management to advertise what they are doing not just only to HCWs and Medical institutions.

I believe that if Management would have appointed a public relations officer then we would most likely not have a share price tumbling from $4.70 in March 2006 to
$1.90 now. Cellestis share price has been falling for a long time not just in 2008.

I reckon that it is very worrying for many shareholders to experience this continuous fall of the share price.

What can we expect to happen if nothing is done about it.

Why is it that management doesn't seem to be interested in the share price? Do they perhaps have other plans?

They seem to have quite an interest in exercising an M&A, what about doing something tangible for the shareholders first!

Shareholders have been waiting patiently for 7.5 years now.


It's about time something gets done.


  Forum: By Share Code

bing
Posted on: Nov 27 2008, 08:49 PM


Group: Member
Posts: 304

Contents of this article doesn't seem to apply to the Board of Directors of Cellestis!

-------------------------------------------------------------


Ask the Expert – Share Trading
Why do companies care when their share price falls?
Matt Comyn, General Manager, CommSec

Today's expert:
Matt Comyn, CommSec
Why do companies care when their share price falls? How is a company affected by a falling share price?

From a transparent point of view it can be confusing to wonder why companies care when their share price falls. After all, listed companies have already received money from investors, when they first sell shares through an Initial Public Offering (IPO). What happens in the secondary market, when investors buy and sell to each other on the ASX, cannot take away from the gains the company has already made.

However, like with most things, the story is a lot more complex than that. Firstly most senior management would generally have a vested interest in the company; therefore their own personal wealth could be dramatically affected by falls in the company’s share price. Secondly, many employees receive performance related bonuses in the form of shares in their company, so effectively act as stockholders of the company and therefore pay strong attention to its share price.

Another pertinent reason is that a falling share price can impact on the reputation of a company, and therefore reflect on its management. If the share price of a company continually underperforms the overall market, shareholders are going to look for someone to blame. From a career perspective and egotistical point of view, management would not want to be heading up a company which is continually receiving bad press, lest it impacts on their own professional futures. Shareholders are part owners of the company and in extreme cases can band together to try and oust management through a proxy vote.

Publicly traded companies which are underperforming also often become takeover targets. If the share price of a company falls substantially, it makes it much easier and much more affordable for a wealthy shareholder or a rival company to move in and buy up a significant amount of stock or launch a takeover offer that shareholders cannot afford to refuse. This is a very big incentive for companies to ensure their stock price remains relatively stable, so that they remain strong and deter interested parties from forcing them into a takeover deal.

The rate and ease at which companies borrow money can also be affected by a falling share price. Creditors tend to look favourably upon companies which are performing well, and may offer them cheaper financing through a lower interest rate.

For all of these reasons, a company’s share price is a serious matter of concern. If performance of a company’s stock is ignored, it can have serious repercussions on the fate of the company and its management.

Disclaimers: The views expressed in this article are those of Matt Comyn, a representative of Commonwealth Securities Limited (CommSec) ABN 60 067 254 399 AFSL 238814. Commonwealth Securities Limited (CommSec) ABN 60 067 254 399 AFSL 238814 is a wholly owned but non-guaranteed subsidiary of the Commonwealth Bank of Australia ABN 48 123 123 124 and a Participant of the ASX Group and the Sydney Futures Exchange. As this information has been prepared without considering your objectives, financial situation or needs, you should, before acting on this information, consider its appropriateness to your circumstances and if necessary, seek appropriate professional advice.

[B][/B]
  Forum: By Share Code

bing
Posted on: Nov 25 2008, 02:58 PM


Group: Member
Posts: 304


A good cause for using surplus cash!!!!


I guess what would be desirable for many shareholders is for the company to use their
resources to put a floor underneath the shareprice.

Like the Reserve Bank who intervenes in the dollar market, Cellestis could also buy and sell shares. This would not mean that they would loose money, on the contrary they could even make some money doing this.

Using their surplus cash and only very little would be needed.

It would not even require a staff member to do this, a broker could be used to do this.
All the company has to do is instruct the broker to maintain a steady share price.

All it needs is trades of 1 share!!!!!!!

Choosing such a way would encourage more would be investors to have confidence to invest in such a stock.

It would certainly help longterm investors maintain a stable portfolio especially those who have borrowed money to buy CST shares.

I think it is legal for them to do this as it is also possible for the company to buy back shares if the shareprice is found to be too cheap.

Maybe someone could suggest this to the management as a good alternative for using surplus cash!
  Forum: By Share Code

bing
Posted on: Nov 11 2008, 09:43 PM


Group: Member
Posts: 304

In reply to: arty on Tuesday 11/11/08 10:26pm



Thanks Arty,

Yes looks like there may be a change in direction.

Similar thing is happening with IIF.

Let's hope we will see some sanity returning to this sector and an improvement in the share prices.
  Forum: By Share Code

bing
Posted on: Nov 3 2008, 04:54 PM


Group: Member
Posts: 304



AOE cash flow statements

http://www.asx.com.au/asx/statistics/annou...&issuerCode=AOE
  Forum: By Share Code

bing
Posted on: Oct 21 2008, 06:40 PM


Group: Member
Posts: 304

Hi All,

Like Forrest is saying, 'we can talk till the cows come home', bottom-line is that no matter what, in the end what counts is 'Show me the money'.

I have been patient for many years now and don't like selling at a loss.

I still believe Cellestis is a good company, but how long can we wait, that is the important question we each should ask ourselves.

As shareholders of large CST parcels we should be realistic and be prepared that there may be a downside risk to holding this stock.

Something somewhere may trigger a reaction.

You only have to go back and remember what happened to Cochlear's share price when it was rumoured that Boston Scientific had a better product, which later on turned out to be wrong. But it had a disastrous effect on Cochlear and its share price. It more than halved the share price and took a while for it to correct itself.

According to reports Bear Stearns was destroyed by rumour and innuendo in one week!

Cellestis has patented Quantiferon but that has a certain shelf life and if another company comes up with an alternative diagnostic tool which could be better and cheaper than Quantiferon then Cellestis share price will change dramatically.

Remember rumour and innuendo may be sufficient to have a disastrous effect on CST share price, and if that happens forget about selling out as this will be impossible with an illiquid stock.

Let's not delude ourselves thinking that this could not happen to Cellestis.

Beginning October I posted the following and this was somehow ignored by SS members as nobody commented on this. But this is another example of how things can drastically change if this BD Company comes up with a better product soon. They already have exposure by being one of XDRTB.org main sponsors.

Quote

Below is the write up about the XDRTB.org's sponsor.

-----------------------------------------------------------------------------------
BD (Becton, Dickinson and Company) is committed to increasing
access to improved TB diagnostics worldwide. BD focuses not only on
ensuring access to its existing TB diagnostic technologies, but also
is investing in much-needed improved TB diagnostics.

BD is a leading global medical technology company that develops,
manufactures and sells medical devices, instrument systems and
reagents. BD is dedicated to improving people's health throughout
the world. BD is focused on improving drug delivery, enhancing the
quality and speed of diagnosing infectious diseases and cancers,
and advancing research, discovery and production of new drugs
and vaccines. BD's capabilities are instrumental in combating many
of the world's most pressing diseases. Founded in 1897 and
headquartered in Franklin Lakes, New Jersey, BD employs
approximately 28,000 people in approximately 50 countries
throughout the world. The Company serves healthcare institutions,
life science researchers, clinical laboratories, the pharmaceutical
industry and the general public.




  Forum: By Share Code

bing
Posted on: Oct 21 2008, 03:27 PM


Group: Member
Posts: 304

Amongst a sea of green we only see a few red ones and guess what CST is amongst these few. Hard to believe that this is still taking place.

This downward trend is becoming a slippery slope from which it seems there is no grip to halt or even reverse the trend.

In the past two weeks we have seen the share price behaving like a roller coaster. Up from $2.08 to $2.60 and back again to $2.01 and now $ 1.95. Up 25% and then down again with the same %.

As usual "When 'o' when will this end?

Despite all the good talk other investors are not yet convinced there is milk and honey coming from investing in Cellestis.

So much for your list Henrietta the other day showing that CST was amongst the least percentage downturn group in a year. With today's result we are on the way to join the other stocks showing large declines in the SP.

Bloodclot, you are spot on in your description of what has happened with this stock.
We are told not to expect management to talk up, but the very opposite of ramping up is happening on a continuous basis, ever since February 2006.

Instead of constantly discussing/ramping up!! the medical acceptance of quantiferon and the googling of quantiferon resulting in excerpts from medical papers we should not forget to discuss the share price performance also. After all we are in it for the money don't we?

Further advancement in the share price should be expected of a stock with such good economic ratios.

One could ask 'Why is Cellestis ignored' and left to be a kicking ball for the bot traders.

This is not because investors do not know how good a company Cellestis really is.

I just like to see some improvement in the share price, now that ever higher profits are achieved.

Let's have some realistic/objective discussion please!

  Forum: By Share Code

bing
Posted on: Oct 8 2008, 07:08 PM


Group: Member
Posts: 304



** Protein key in new uni TB vaccine **
Research by scientists in Wales and Russia is being used to develop a new vaccine for tuberculosis.
< http://news.bbc.co.uk/go/em/fr/-/2/hi/uk_n...id_/7656676.stm >
  Forum: By Share Code

bing
Posted on: Oct 5 2008, 10:50 AM


Group: Member
Posts: 304

In reply to: forrestgump on Sunday 05/10/08 07:02am


Yes I agree it is very disturbing to see the Nachtwey photographs.

It seems that there is no mention of Cellestis or Quantiferon as a diagnostic tool, yet
this other company (Becton, Dickinson) gets a lot of exposure.

Question, what do we know about BD's TB diagnostic capabilities. Have they already got something on offer to compete with Quantiferon?

Below is the write up about the XDRTB.org's sponsor.

-----------------------------------------------------------------------------------
BD (Becton, Dickinson and Company) is committed to increasing
access to improved TB diagnostics worldwide. BD focuses not only on
ensuring access to its existing TB diagnostic technologies, but also
is investing in much-needed improved TB diagnostics.

BD is a leading global medical technology company that develops,
manufactures and sells medical devices, instrument systems and
reagents. BD is dedicated to improving people's health throughout
the world. BD is focused on improving drug delivery, enhancing the
quality and speed of diagnosing infectious diseases and cancers,
and advancing research, discovery and production of new drugs
and vaccines. BD's capabilities are instrumental in combating many
of the world's most pressing diseases. Founded in 1897 and
headquartered in Franklin Lakes, New Jersey, BD employs
approximately 28,000 people in approximately 50 countries
throughout the world. The Company serves healthcare institutions,
life science researchers, clinical laboratories, the pharmaceutical
industry and the general public.


  Forum: By Share Code

bing
Posted on: Sep 18 2008, 03:47 PM


Group: Member
Posts: 304



It seems as if the bot traders are trading at full throttle today, with the help of many desperate sellers.

Some very very small volumes are going through but then also some very large ones, i.e. one transaction involving 19,500 shares @ $1.95.

They reckon we haven't seen the end yet of the Wall Street turmoil. More financial institutions will fall, causing further falls on share markets.

Some say expect another 10 to 20% fall on the Dow and other indices.

Should we sell to preserve capital? With hindsight we should have sold when CST was trading at higher levels, but then who would have expected to see Cellestis at these prices.

Question is, how long do we have to wait for share prices to go back up again.

They say bear markets on average take 15 months to play out, but what we see happening now is very unusual.

The destruction of Wall Street reminds us what happened during the Great Depression. It took until 1954 for the share market to get back to the levels of 1929.

My hope is that we do not have to wait that long for our share market to get back to previous highs.

  Forum: By Share Code

bing
Posted on: Sep 15 2008, 08:01 PM


Group: Member
Posts: 304


The impact of Lehman Brothers going belly up and Merrill Lynch involved in a fire sale to Bank of America.

There is expectation that the Dow may drop 700 points tomorrow or more than 5%.


So expect more blood letting.



The Aussie market often tries to outdo the American market so let's see if Cellestis likes to play contrarian.

  Forum: By Share Code

bing
Posted on: Sep 15 2008, 10:34 AM


Group: Member
Posts: 304

In this Weekend Finrev, page 14 is this short news snippet

"Cape Lambert readies Pilbara drilling"

Cape Lambert Iron Ore says drilling will start on its Cape Lambert South project in Western Australia's Pilbara after it was granted an exploration licence.

------------------------------------------------------------------------------


Who knows what is out there but let's hope high quality iron ore.
  Forum: By Share Code

bing
Posted on: Sep 12 2008, 03:24 PM


Group: Member
Posts: 304

When Will It End ?

For quite a while now we have seen the SP going down more and more.

Nothing seems to have any influence on CST' share price. Even when the market goes up, Cellestis share price keeps going down.

Cellestis has only one influencing factor and that is, buyers decide what price to pay.

Each day one can see before opening that the bid price is always below the previous day closing price and the sellers must be pretty desperate to sell at lower and lower prices, as often after lunch they have been stared down and they succumb to accepting again a lower price.

There is just no interest from investors/institutions to buy Cellestis shares.

How can this has been happen with such good financial news been reported.

This company has no financial debt and has cash in the bank, this is regarded as a plus when deciding which share to buy.

Are they all deaf or what!

There can be no profit for bot traders with a sinking share price, not even shorting will work, as this is an illiquid stock.

So who are these sellers?

Again "When will this end"!

Posters on this thread have been saying for quite a while now, "when profits are made the market will take note and investors will be interested to acquire Cellestis stock!

But so far this is not happening!

When 'o' when will this end?

  Forum: By Share Code

bing
Posted on: Aug 25 2008, 11:55 AM


Group: Member
Posts: 304

In Saturday's SMH ibahealth placed an add for a

Head of Corporate Affairs.


Contents of ad are as follows;
--------------------------------------------------------------------------------------------------------


. Global greenfields opportunity
. ASX-listed healthcare technology
. Media & Investor relations focus

IBA Health Group Limited (ASX:IBA) develops, delivers and supports fully integrated technology solutions across all health sectors. With a market capitalization of around $500M, our global team of 3700 health and technology professionals are dedicated to delivering sophisticated solutions that connect healthcare providers, payers, patients and communities.

Due to impressive growth, particularly within the last twelve months, IBA Health has now committed to developing an inhouse corporate affairs function. Reporting to the CEO and Executive Chairman, this role will see develop a global corporate affairs strategy focusing on corporate and financial communication. This role will provide strategic counsel to the CEO and leadership team, whilst also playing the main role in implementation.

This role will particularly suit a high-calibre and ambitious mid-level executive who is looking to take their career to the next step. The successful candidate will need to demonstrate high levels of initiative and the ability to work autonomously in order to thrive in the fast-paced and collegiate organisation.We require an individual who will be happy to balance strategic responsibilities with the realities of working in a "hands-on" environment.

Please call Josh Shein of Salt&Shein on 02 9947 9733 or on 0413 616 896.

Australia(Head Office).China.Germany.India.Ireland.New Zealand.Singapore.Spain.Thailand.The Netherlands.South Africa.United Kingdom
www.ibahealth.com

Anyone interested ?

Looks to me the company is now going into overdrive to get results on the board quick.



  Forum: By Share Code

bing
Posted on: Aug 21 2008, 10:46 PM


Group: Member
Posts: 304

In reply to: forrestgump on Thursday 21/08/08 10:17pm


Forrest,

The reason I chose 4 years is because that is when I started to invest in Cellestis (i.e Oct 2004)

True 7 years ago CST started at 25c and went as high as $4.60 only to fall back to $2.16, a drop of 53%.

This we have not seen happening with BHP. It has fallen from its high but no where near as much.

Investors who invested in CST when it was trading in the high $4.00 watched it to see the share price dropping and dropping and if invested in BHP would not have experienced this.

It will indeed be interesting to see how the two companies will perform in the next 4 years.

Let's be frank most of us are investing our hard earned money to make money and not to proof why we are investing in company A or B.

Investing is done only to get a good return and most couldn't care what the company sells as long as it makes sense.

Such as - invest in companies which sells products you use - that makes sense.


  Forum: By Share Code

bing
Posted on: Aug 21 2008, 09:45 PM


Group: Member
Posts: 304

In reply to: forrestgump on Thursday 21/08/08 08:10pm


It is very easy to make comparisons with a failed and highly geared company such as Babcock and Brown.

But let us try to be objective.

As mentioned the opportunity cost of having been invested in Cellestis should be compared with easy alternative companies such as BHP, Rio.

Companies which everyone can understand, no rocket science required here.

Having been invested in Cellestis for 4 years now ,the comparison shapes as follows.

BHP in Aug 2004 traded at $13.21 and today it closed at $38.95.
This represents a rise of 195% plus fully franked dividends of approximately 2% each year.

Not such a fantastic dividend but as they say one should invest for a combination of growth and yield.

Cellestis traded around $2.50 mark in August 2004. It has risen to $4.60 in Feb 2006 only to fall back and at the of December 2007 it finished at $3.08.

Today it closed at $2.16.

This shows the hugh difference in return on investment with a company like BHP.

So far we have not seen dividends from Cellestis in 7 years of existence and to make up the difference with BHP the company has to pay out hugh dividends per share and a comparable rise in share price.

Let's not fool ourselves - this I feel is a necessary calculation we all should make - required to remain objective for having supported this company for this long.


  Forum: By Share Code

bing
Posted on: Aug 20 2008, 09:51 PM


Group: Member
Posts: 304

What happened today that the share price dropped so much in one day, 20c or 7.09%


Goodman did well in August after reaching a low of $2.33 on 5th August and gtouched a high of
$3.02 on 18th.

Yet most of the other property stocks did not do so badly.

Westfield went up 46c or 2.93%

If GMG drops any further perhaps we should top up!

Can anyone provide an explanation ?
  Forum: By Share Code

bing
Posted on: Aug 16 2008, 07:55 PM


Group: Member
Posts: 304

In reply to: bing on Saturday 16/08/08 07:52pm



Sorry , forgot to mention!


The 2nd link shows the article about Cape Lambert at the lower part of the column by Criterion's Tim Boreham.
  Forum: By Share Code

bing
Posted on: Aug 16 2008, 07:52 PM


Group: Member
Posts: 304

Two recent articles in yesterday's The Australian.

Interesting to read!

All doesn't seem to be above board and management issuing 8.35 million options to employees at 50c without shareholder approval sounds unethical in my opinion.

No wonder the share price slumped!


http://www.theaustralian.news.com.au/story...2-16941,00.html

http://www.theaustralian.news.com.au/story...5-23634,00.html

  Forum: By Share Code

bing
Posted on: Aug 7 2008, 09:30 PM


Group: Member
Posts: 304


What a day it has been!

Perhaps we could say, a day, without any (trans) action.

I can't believe there is no discussion on this thread about the abominable performance of this supposedly wonderful stock.

Wonderful for whom you may ask, certainly not the average investor.

We have been hanging in there for another terrible 7 months. The share price has dropped from $3.08 to $2.24 ytd.

A drop of 27.2 percent. Again!

And this for a stock which has good sales, no exposure to sub-prime problems, no adverse debt/equity ratio, so WHY is this stock so unloved.

Is it because so few people believe in the business model of this company?

The result of today's transaction just proves the point. No interest/demand, only 2 transactions occurred after 2.00pm.

Indicative is how the sell and buy sides lined up today. This morning it started with a sell offer of $2.30 and on the buy side $2.24.

The sell offer changed to $2.29 only to be stared down and whoops the transaction occurs after a long wait, with the buy side winning with a $2.24 transaction.

What does that say about this stock, that the buyers are in control!

The share price is constantly forced down, why because there is no demand and with an illiquid stock like Celllestis the bot traders can do what they like.

Almost every other stock showed some respite, even the financials had a good result this week but not Cellestis.


What's wrong with this stock!


Will it ever show a proper return for the long suffering investors.

I know there are those who say please be patient, but how long do we have to wait.

The same conversation took place several times in the past, but instead of going up the share price drops more and more.

One could have expected a higher share price based on higher sales and more profits.

Yet that does not seem to impress investors.


Even in this bear market there are shares which go up in price!!!!! Not CST!!!!!


I am looking forward to some honest/objective and meaningful discussion.
  Forum: By Share Code

bing
Posted on: Jul 28 2008, 05:49 PM


Group: Member
Posts: 304

News article appears on CompareShares website at 5.13pm today called

"Cape Lambert expects Russian bid soon"



Did not explain why the share price took a nosedive of 32.3% today?


http://www.compareshares.com.au/show_news.php?id=S-501061


[B]
  Forum: By Share Code

bing
Posted on: Jul 4 2008, 08:13 PM


Group: Member
Posts: 304

WOW Nice finish for the week!!!

Up 10%

Closing price 77c


$1 here we come.

Let's hope so.

  Forum: By Share Code

bing
Posted on: Jun 16 2008, 08:49 PM


Group: Member
Posts: 304



Had a telephone conversation with Mr Tim Turner,
Non Executive Director - Company Secretary, he confirmed that Cape Lambert would continue as an exploration company.

Interested in finding other deposits. He also confirmed that they would stick to looking for iron ore deposits and not other minerals.

with so much money in the bank soon, there is plenty of scope to explore vast areas and they have the expertise in house to do it.

Total shares outstanding say approx 250m it seems to me the share price can go quite a bit higher.

  Forum: By Share Code

bing
Posted on: Jun 16 2008, 02:10 PM


Group: Member
Posts: 304

In reply to: elleburra on Monday 16/06/08 01:48pm



Doesn't seem to impress the market as it move so easily down 10cents and that with only
400 shares transaction.

When will the market take note and lift their lazy finger.

This is a very good result but yet there is still no interest shown so far.

  Forum: By Share Code

bing
Posted on: Jun 13 2008, 10:06 PM


Group: Member
Posts: 304



There is more to explain the heightened interest in CFE today.

article in The Australian says it all

Russians spot Lambert !!!!!!!


http://www.theaustralian.news.com.au/story...52-15023,00.htm

Could be an interesting time next week when the Russians sit down with CFE management to
talk shop.

I am getting exited too now about possible higher offers from others.

Happy to continue holding!
  Forum: By Share Code

bing
Posted on: Jun 13 2008, 04:36 PM


Group: Member
Posts: 304



Let's change the subject and discuss the share price performance of Cellestis for a while.

Again a drop of 14c or 5.09% today. Finshing at $2.61 Auch!


Just my observation but I thought after the big jump of 42c on Monday 2nd June it would break through the $3.00 barrier in the next couple days and maintain this level hoping it would rise to even higher levels, but to no avail, it has tricked us again and almost lost this gain of 42c completely since then.

The volume has not changed much so it is still a very illiquid stock and therefore the bot traders can do what they like.

Still waiting for the big spike!

When 'o" when will this happen.

Anyone else interested to voice their opinion on Cellestis share price performance?







  Forum: By Share Code

bing
Posted on: Jun 13 2008, 04:13 PM


Group: Member
Posts: 304


Trading finished and to my surprise the share price did quite well today.

3.5c or 5.19% today, who knows where this may lead to.

Does this mean that now MCC has paid $400m, CFE will cease to exist?

What about the shareholders will they be bought out and if so at what price?

Can anyone shed some light on this?
  Forum: By Share Code

bing
Posted on: Jun 12 2008, 01:14 PM


Group: Member
Posts: 304




Cape Lambert signs sale agreement with MCC





http://www.theaustralian.news.com.au/story...5005200,00.html[U]


What impact will this have on the share price?
  Forum: By Share Code

bing
Posted on: May 22 2008, 02:06 PM


Group: Member
Posts: 304

Article in The Australian on Tuesday 20th May 2008 called

"Keeping Darwin on Track"

This article deals with the operation of the railway line Adelaide to Darwin.
Freightlink doesn't make a profit but they don't want to stop using it.


Mentioned in there is Arafura as a potential customer with others like
Territory Resources and next year Oxiana and IMX Resources.

Quote
However, Arafura Resources is planning to move 800,000 tonnes a year
by rail from its rare earths-phosphate project in the NT to either Darwin or Port Pirie
(either option meaning good revenue for the rail operator). Oxiana and IMX Resources are looking at sending concentrates from deep in South Australia north to Darwin by rail,
a haul of more than 2,000km that would be the longest train journey for ore in Australian
history.
Unquote

Seems things are starting to happen, question is, when are they ready to start doing it!
  Forum: By Share Code

bing
Posted on: May 5 2008, 03:36 PM


Group: Member
Posts: 304

What's wrong with ALS?

Recent high of $10.79 on 8th Feb 2008 and it keeps dropping since.

Today's price $831, down 11cents!!!!!!!

This is a drop of close to 23%!!!!

For what reason may I ask.

Does anyone know?
  Forum: By Share Code

bing
Posted on: Apr 27 2008, 10:00 PM


Group: Member
Posts: 304

In reply to: arty on Sunday 27/04/08 09:30pm



Another good freebie is

jZip

# Create, open and extract Zip, TAR, GZip and 7-Zip. Open and extract from RAR and ISO.
# jZip is absolutely FREE for everybody, home and enterprise users
# jZip is an easy to use and fast archiving software

http://www.jzip.com/
[U]
  Forum: Off Topic Chat

bing
Posted on: Apr 16 2008, 04:00 PM


Group: Member
Posts: 304




Some positive publicity !!



http://business.smh.com.au/medicine-for-an...0416-26gz.html#
  Forum: By Share Code

bing
Posted on: Apr 16 2008, 03:59 PM


Group: Member
Posts: 304




Some positive publicity!!!


http://business.smh.com.au/medicine-for-an...0416-26gz.html#

  Forum: By Share Code

bing
Posted on: Apr 16 2008, 03:58 PM


Group: Member
Posts: 304



Some positive publicity !!



http://business.smh.com.au/medicine-for-an...0416-26gz.html#

  Forum: By Share Code

bing
Posted on: Apr 16 2008, 03:56 PM


Group: Member
Posts: 304



Some positive publicity!!!


http://business.smh.com.au/medicine-for-an...0416-26gz.html#
[U]
  Forum: By Share Code

bing
Posted on: Apr 16 2008, 02:59 PM


Group: Member
Posts: 304

In reply to: hagar on Wednesday 16/04/08 01:56pm

Good stuff !!

This is the sort of publicity we have been waiting for, good that it is here.

Maybe to generate more interest in Cellestis perhaps it would be a good
idea to repeat your post on other biotech threads in Sharescene.
  Forum: By Share Code

bing
Posted on: Apr 15 2008, 08:16 PM


Group: Member
Posts: 304

In reply to: elleburra on Tuesday 15/04/08 07:04pm







Ditto !!!!!!!!!!!!!!!!





  Forum: By Share Code

bing
Posted on: Apr 13 2008, 02:38 PM


Group: Member
Posts: 304

In reply to: kahuna1 on Sunday 13/04/08 01:28pm


There is a listing in the Weekend Finrev of all the companies in which ANZ has a holding interest.

All in all 55 companies are listed and amongst them is Solagran.

Heading: Substantial stakes in Opes-affected companies held by ANZ- As of close of trading on April 10.

Details are as follows;

ANZ stake 42.57%
Status: A controlling stake in the Melbourne pharmaceutical company remains on market.
Share price over week: -43.97%

Does this mean that the slide in the share price is caused by ANZ selling Solagran shares to recoup outstanding loan OR is something more sinister occurring.

Question: Does this mean that ANZ continues to be a large shareholder of Solagran? If so why then did the share price go down so much.

Question: Is it a big risk to buy into Solagran at this stage. I have not sold any!

  Forum: By Share Code

bing
Posted on: Apr 10 2008, 01:34 PM


Group: Member
Posts: 304

Robots are at work again!!

Didn't last long did it, before they were back at work again.

Seemingly no issues with regulators, unlike some of Opes' affected stocks.

When will it stop having an effect on this stock. Most likely when there is more liquidity!

But how do we get that?

Noteworthy the headlines in today's AFR say "Opes probe widens to share price manipulation"

We were already suspicious that this took place but now it may be surfacing for everybody to see!

  Forum: By Share Code

bing
Posted on: Mar 29 2008, 08:56 AM


Group: Member
Posts: 304

In reply to: bing on Friday 28/03/08 10:54pm

Perhaps shares are sold willy nilly by lenders to recoup money given as margin loans.

I am referring to the likes of Opes and Tricom.

A must-read story in the Saturday Morning Herald, page 45 by Ian Verrender called

"Opes collapse could reveal a sordid tale of short-selling super"

Just shows that Australian regulators are very lacks when it comes to short selling. Despite all the sub-prime mortgage problems in the US, this could not take place over there.

The hedge funds have been getting away with doing things they could not do in other share markets. It gives them scope to really hurt our stocks and cash in at the expense of small investors and people with margin loans.

Any wonder our share market went down more than the Dow, yet there is were the problems occurred in the first place. Crazy!!!


  Forum: By Share Code

bing
Posted on: Mar 28 2008, 09:54 PM


Group: Member
Posts: 304

Noticed this transaction which took place at 4.23pm

25,000 shares sold/bought for 24c , total value $6,000
Condition XTSXOS

Don't know what this means, but could be a transaction between two agreeing parties.

Anyone know more?

I am surprised though at the volumes offered for sale at these low prices.

On the sell side some are offering to sell 25,000 at 46.5c and 20,000 at 47c , then 10,000 at 47.5c, 62,548 shares at 47.5.

You wonder though if they are selling because of margin calls, because can't believe they are selling at a profit, as who has bought IBA at even lower prices than what is traded now.
  Forum: By Share Code

bing
Posted on: Mar 28 2008, 07:37 PM


Group: Member
Posts: 304

Good move today, closing at 65c!!! WOW

Haven't seen such a large % rise for a long while.

Let's hope it continues its march north.

Can we expect a share price worth $1 soon?

Who knows, anything is possible these days.
  Forum: By Share Code

bing
Posted on: Mar 27 2008, 06:51 PM


Group: Member
Posts: 304

TB speech in the Senate was discussed and reported in the 7.30 Report this evening.
Reporter was Natasha Johnston

Let's see if we can view this clip on video.

Important contribution to the report was made by

Assoc Prof Paul Johnston

Dr Ivan Bastian

Dr Rob Pierce

Dr John Carnie

Good publicity but no mention of Quantiferon or Cellestis.

Management needs to communicate with these people to make them aware of Quantiferon.
  Forum: By Share Code

bing
Posted on: Mar 19 2008, 06:46 PM


Group: Member
Posts: 304

Thanks Puzzled for the link.

I have copied and pasted the speech here.


SENATE Tuesday, 18 March 2008

Tuberculosis and HIV
Senator MOORE (Queensland) (9.25 pm)—
Wandering through the first floor public area of this
place the other day, I came across a corrugated iron and
sacking shack. The shack popped up in the middle of
our public area and is the creation of a young South
African artist, Damien Schumann, who has been tour-
ing the world, creating knowledge about the scourge of
TB in poor societies.
Several years ago Mr Schumann began creating a
photographic essay of families and human beings who
are affected by the double impact of TB and HIV in
South Africa. We know about the horrors of this condi-
tion, because many books and many articles have been
written about it. But, somehow, the gallery space that
Mr Schumann has created, which he has filled with his
confronting photographs of families and individuals
and graffiti-like stories about the people who are living
and dying with this condition in South Africa, can get
the message across much more strongly than people
just talking about it or reading books. In fact, this dis-
play, which we are privileged to have in our place of
work, has been touring since 2006, when the original
display called, The Shack and Dialogues: Understand-
ing Tuberculosis, was opened by Archbishop Tutu.
Archbishop Tutu has himself survived TB, and this is
an issue I did not know about, even though we have
learned so much about this man. He was able, in
launching this exhibition in his home, to talk about
what it meant to him and to the people in his country
and to talk about how serious this condition is, how it
is a growing scourge and how it can be helped by ap-propriate
medication and lifestyle.
The exhibition has toured extensively and, after it
has been taken down from our area, it is hoped that it
will move on to Mexico. In talking to Mr Schumann he
said that he has become a master at putting the shack
up and taking it down, and he was able to tell me about
the various photographs that he has displayed. He
talked about the people he has met, about the hope that
they have and about the particular worry that tubercu-
losis spreads so quickly—so quickly that many of the
stories that are on the walls of the shack relate to fami-
lies. There are many up there, but I just want to talk
about a couple. When you stand and read the stories
and look at the photographs, you cannot help thinking
about the families you know and place yourself in their
positions.
There is a photo there of a young man called Flloyd.
He is eight years old and has, unfortunately, the double
whammy of being HIV positive and having TB, but he
is recovering well now with effective medication. He
first went to a transit home—which is the process that
is often used in South Africa; it is a bit between a hos-
pital and a home—when he was suffering from pure
malnutrition. Through domestic violence at home he
had a broken arm. No-one cared for him when he was
found because none of his family would go near him as
he stank so much. This is one of the side effects of tu-
berculosis. It is something we read about in the history
books in our country, because, in the long distant past,
tuberculosis was quite strong in our country. I remem-
ber reading stories about country hospitals in Queen-
sland which told of the enormous work that nurses did
in that area. One of the things that people wrote about
was the fact that there was a smell, and that was some-
thing that the hospital workers had to work with. In
Flloyd’s case, it was one of the things that kept him
isolated and marginalised from his community.
Flloyd also had terrible scars on his stomach from
the blisters and sores that come from HIV. He has a
long scar—and in the photograph you can see it—
which is a reminder of when he fell into a fire. We in
Australia know the dangers of open fires and that this
is something that happens a lot in camping communi-
ties, but the dangers are much more when we are talk-
ing about people living in poverty in camp towns in
South Africa. The story is that both Flloyd’s parents are
dead but he, by being found and given strong treat-
ment, is healthy and attending school. There is a pho-
tograph there in the shack of him living happily with
his new family at the transit home. The thing I liked
particularly in the story—and he has a large smiling
face—is that it says he loves to dance. So when you
hear that horror story, you see that change can have an
impact.
In the Millennium Development Goals, which we
have talked about in this place before, one of the spe-
cific goals, goal 6, is to turn around HIV-AIDS, ma-
laria and other major infectious diseases. Indeed, tu-
berculosis is one of those infectious diseases. And there
can be a difference. The Stop TB Partnership, which is
a network of public, private and civil society organisa-
tions, has developed six straightforward goals to elimi-
nate TB from the world by 2050. That is a fair way
away, but we have to have that length of time to ensure
that all the streams of commitment can come together.
We can have, under the 10-year plan of 2006-15, a
global plan to stop TB which fits in with the MDGs.
We can, by 2015, halve tuberculosis prevalence and
death compared with that which was itemised in 1990.
By 2015, with effective, sufficient global funding, 50
million people will be treated for TB across the
world—14 million lives can be saved. We can intro-
duce, through strong research—and Australia is a
leader in this area of medical research—better, more
effective and more responsive TB drugs. Most impor-
tantly, through the global fund, we will be able to en-
sure that this medication is available and accessible to
countries like South Africa and, most particularly, our
closest neighbours, because one of the areas where the
rates of TB and the horror of HIV are growing most
rapidly is PNG, in the Pacific.
We know that in Australia now the incidence of TB
is relatively low. Our figures indicate that in 2005 only
1,072 cases were reported and that the annual figures
in Australia have remained stable. It is particularly im-
portant for us in this country to understand how easily
this disease spreads and to know, with the way that
international travel is increasing and people are coming
in and out of our country, that at all times we must be
vigilant to ensure that the horrors of TB do not come in
more easily to our own country. We also know—and
this is from international medical practice—that un-
treated TB is one of the leading killers of people with
HIV, reducing life from years to months. TB can be
effectively cured in individual cases with a six-month
course of antibiotics. For us in this country that is
something that is easily achievable. What we must en-
sure is that we share the knowledge and the medication
across the world.
When we see the faces of the people in the display
upstairs, we can see what a difference we can make.
When Mr Bob McMullan, the Parliamentary Secretary
for International Development Assistance, opened the
Parliament House display last week, he talked about
the fact that we will continue to contribute to the inter-
national global fund and that our contribution from
Australia can make a real difference. We have no op-
tion but to be part of this international program. Dis-
plays such as the shack will make sure that we have
knowledge and that we can move knowledge across
our country much more quickly.
I went up a couple of times to see what impact the
display was having on all the visitors to Parliament
House. It is quite interesting to watch the faces as they
walk through the public spaces upstairs. One of the last
things you would expect—it is always very difficult to
say ‘the last thing you would expect’—while wander-
ing through Parliament House is to find a South Afri-
can shack, and I think that that in itself creates a mes-
sage almost immediately. To see the groups of school-
children who are visiting here as part of the parliamen-
tary education program, to see and to hear their ex-
citement as they are taken through the shack and see
photographs of kids their own age, is a joy. They share
the experience of their own healthy and often loved
lifestyle here, and they see the stories of people like
Flloyd. That actually shares knowledge; it also garners
commitment.
What we hope to get out of this display is not just a
pleasant time, having a look and saying, ‘Isn’t that ter-
rible,’ but people going out into the community—
particularly those young people—talking about the
experiences, the impact of HIV and TB in any commu-
nity, and making sure that they can be part of the dif-
ference. That is the joy of the experience. That is why I
want to particularly congratulate the President of the
Senate and the Speaker of the House, who, by their
efforts, gave the approval to have the shack and the
display in the public area. It makes a difference. We
can learn and we must continue to make our share of
commitment to the global fund so we can beat this hor-
rible disease.





  Forum: By Share Code

bing
Posted on: Mar 19 2008, 10:09 AM


Group: Member
Posts: 304

Yesterday evening at around 9.30pm I had the car radio on and was listening to Newsradio.
It was broadcasting Senate speeches and TB was discussed by a lady member.

She was talking about TB in Australia and the rest of the world and that it would be eradicated by 2050.

Has anyone else heard this broadcast and is there a way of retrieving this in written form or audio.


  Forum: By Share Code

bing
Posted on: Mar 18 2008, 08:05 AM


Group: Member
Posts: 304

Thought to buy some more CBA shares and placed my order yesterday below the 52 week low of $37.56.

Placed order at $37.50 only to note that it touched a low of $36.98. So my order was filled, had I been at my desk I would have changed the details.

After this Bear Stearns debacle, wonder where our financials will be heading today.

More downside to be expected today for the banks?

Who knows?

  Forum: Investment Discussion

bing
Posted on: Mar 17 2008, 10:50 AM


Group: Member
Posts: 304

CST probably likes to out do the Banks in tanking

Sub $2 here we come!

Nothing new, seen it all before.

But am surprised we need to revisit the $2 level again and again with so much good news on the table.

As usual no buyers.
  Forum: By Share Code

bing
Posted on: Mar 11 2008, 12:15 PM


Group: Member
Posts: 304

In reply to: Clocker on Tuesday 11/03/08 11:44am

You have found similar info about Allco being a large shareholder of IBA Health.

This relationship does explain a lot if you consider the hammering which has been applied to IBA.

10% down yesterday and again 10% today.

Let's not forget that IBA's SP was 91c at years end. Touched a low of 40c today, that's a drop of more than 55%, absolutely crazy.

Wish I had known all this then I would have postponed buying more.
  Forum: By Share Code

bing
Posted on: Mar 10 2008, 07:09 PM


Group: Member
Posts: 304

Just looking at some details.

According to Aegis Research, the biggest shareholders of IBA Health Group Ltd are

No Name % Holding
1 AEP Financial Services Holdings Pty Ltd 26.4%
2 D R Coe 23.0%
3 Allco Finance Group Ltd 20.0%
4 RJL Group 19.9%
5 Torex 7.7%
6 Capital Partners Group 7.6%
7 IBA Health Ltd 6.6%
8 Oman Computer Services 5.5%
9 Merrill Lynch & Co..Inc 5.4%

and wasn't Mr David Coe chairman of the Allco Finance Group, now resigned!

So perhaps the selling of IBA shares could have come from Allco, having to meet a debt repayment deadline.

and Aegis Research has a forecast for EPS change for 2008 at -9.1% and no dividends for 2008 either!

Can somebody verify this information is correct.


Interesting stuff and it begins to unravel now and to my mind could possibly explain this sell off.






  Forum: By Share Code

bing
Posted on: Mar 10 2008, 03:41 PM


Group: Member
Posts: 304

Can't understand the hammering of the share price today.

10% down !!!!!

Mind you the whole market went down today but this is a big drop for a quality share like
IBA! There must be short dealing at play as I can't find any other explanation for the
share price movements this calendar year.

No matter what the management does i.e good sales and good reports and good fundamentals, it has no impact on the traders who reckon they can make big bucks short trading this stock.
There is sufficient liquidity to do this.

Look at it, 348 trades today and a volume of 2,344,933 shares.

When will this haemorrhage stop?
  Forum: By Share Code

bing
Posted on: Feb 28 2008, 07:09 PM


Group: Member
Posts: 304

The SBS TV newsvideo clip can be seen on

http://news.sbs.com.au/worldnewsaustralia/

click on Watch Online tab and then after new window opens scroll down to 3.45pm on the rhs.

  Forum: By Share Code

bing
Posted on: Feb 28 2008, 06:45 PM


Group: Member
Posts: 304

On SBS 6.30pm News today a report claims a new tuberculosis drug has been devevolped.

It showed TB patients in South Africa being injected with this new drug, which was developed in Oxford UK.

This I think was in response to the WHO report yesterday and the frontal attack needed said Dr Mario Raviglione.

What impact will this have for Cellestis and the uptake of test kits?

Yet they did mention at the end of the newsclip that the drug would possibly be market ready by 2015!!!!

  Forum: By Share Code

bing
Posted on: Feb 27 2008, 09:03 PM


Group: Member
Posts: 304

Hi Rozella,

Regarding the dividend from BBI, do we know already how much will be paid and when?

Thanks

Bing
  Forum: Investment Discussion

bing
Posted on: Feb 27 2008, 05:29 PM


Group: Member
Posts: 304

Surprise Surprise!

EMU Nickel started trading today at 1.00pm!

Opened at 39c and closed at 35c!

58 trades and 1.272 million shares traded!

What to expect tomorrow huh?

  Forum: By Share Code

bing
Posted on: Feb 27 2008, 04:56 PM


Group: Member
Posts: 304

Does anyone know?

Has there been any further communication from www.Member-Insight.com about
Cellestis since 2006?

If there is can you post the link to the pdf file please.
  Forum: By Share Code

bing
Posted on: Feb 27 2008, 02:23 PM


Group: Member
Posts: 304

From the newsletter I received this afternoon, the author reckons the following occurred!

He reckons it all happened because of CFD and trading stop loss orders. As IBA did not put the result out before the market opened, it did not give the market enough time to digest the information and since it had actually run up to 67.5c this mornng, the first signs of anyone taking profits or selling to cash in caused a cascading effect.

This can be seen from the intraday chart where the moment the sell orders where hit by stop loss orders this turned into a compounding effect.

Resulting in a sell down to a low of 53c!!!!!!!! Unbelievable for such a good stock.

Today's selling can be totally attributed to retail based stop loss orders, that were triggered once 63c was traded through.

Lucky I did not have a stop loss in place and happy to stay in.

  Forum: By Share Code

bing
Posted on: Feb 27 2008, 12:27 PM


Group: Member
Posts: 304

The market was spooked by the apparent loss incurred with the iSoft integration!

Where to from here?

========================================


ANNOUNCEMENT TO THE ASX


Results for the half year to 31 December 20071


Sydney – Wednesday, 27 February 2008 – IBA Health Group Limited (ASX: IBA)

IBA Health Group Limited (‘IBA’) has recorded revenues of $102.8 million, up 183%, and an underlying EBITDA of $25.4 million, up 60% (H1 FY07), reflecting the two-month contribution from iSOFT which was acquired in October 2007. The underlying results are before integration, amortisation of intangibles and one off acquisition costs of $18.2 million.

The integration and one off acquisition costs have impacted the reported 6 month result, producing a net loss after tax of $1.2 million for the period.

The combined business now has a substantial base of contracted and recurring revenues which will underpin future growth. Over 80% of FYO8 revenues are contracted or expected, with recurring revenues of over 60%.

The company has provided guidance for full year FY08 revenues which are expected to be in the order of $380 - $400 million. The company is forecasting underlying FY08 EBITDA in the range of $85 - $95 million.
The company also forecasts that it will produce a reported FY08 net profit after tax, after allowance for the amortisation of intangibles, financing charges and one off costs. EBITDA and profit are anticipated to improve in FY09 with increases to revenue and the benefit of further cost reductions.

Integration of iSOFT into the IBA business is proceeding to plan with targeted cost synergies of $27 million for FY09. $16 million of annualised synergies have already been extracted. One off integration costs of $6.5 million were incurred over the period of which $3.4 million is reflected in this result.
  Forum: By Share Code

bing
Posted on: Feb 21 2008, 02:57 PM


Group: Member
Posts: 304



The only reason as I see it is that these so called BOT traders are able to get away with their game, is because this stock has no buyers.

By that I mean investors who like to add more shares and new investors attracted by the stock's potential. These are just not present. WHY??

Well I think Cellestis is not known outside a small arena of longterm shareholders.

Then here we go again, some say the share price is not important it is the fundamentals they say which are relevant.

But then there are those in the know who say, "IT IS ALL IN THE SHARE PRICE"

and you ignore at your own peril!

I think there is truth in this, just look at CST share price history.

A wonderful set of HY figures are produced and what happens to the SP? Down it goes instead of leaping up.

Every other company with the potential for profits like Cellestis would be a sought after stock. Why is Cellestis so different from the main stream?

Some say Cellestis is not worth much judging by it's net worth, but then which company' share price is valued based on its net worth. Lots of companies share price are no reflection of their net worth.

Ultimately the share price is established by investors willing to buy/sell at an equilibrium price and that is based on nothing else but sentiment.

People pay what they think something is worth. If it is too expensive in their eyes then no sale.

We can all argue until the cows come home, but we must admit one thing and that is that it is very very strange what is occurring with the Cellestis share price.

One wonders, what WILL make a difference if making profits is not a reason to be interested in a company and buy its shares.

I would love to know the answer to this and I think many others would too.




  Forum: By Share Code

bing
Posted on: Feb 12 2008, 06:24 AM


Group: Member
Posts: 304

In reply to: LordSpesh on Monday 11/02/08 04:18pm

Whilst roaming around came across this software company who makes charting, technical analysis and portfolio tracking software for Macs.

Latest update is ready for Leopard.

http://www.beesoft.net/

  Forum: Investment Discussion

bing
Posted on: Feb 7 2008, 01:10 PM


Group: Member
Posts: 304

In reply to: Tony Giglio on Thursday 07/02/08 12:37pm

I have a Macbook Pro and use Parallels Desktop for running my Windows based programs.

Would like to use Mac OS but my programs do not have an equivalent Mac version.

such as Commsec Professional Trader etc.

  Forum: Investment Discussion

bing
Posted on: Feb 5 2008, 04:19 PM


Group: Member
Posts: 304

From CompareShares.com.au

Interesting to read!



-------------------------------------------------
Around the traps with the Ferret


RWE
05/02/2008 12:12pm Email to a friend Print article
i

ARROW ENERGY (ASX:AOE) had its busiest day for more than 12 months on Monday - maybe its busiest day ever - as the price soared 49.5c to as high as $2.34 and closed at $2.27, earning itself an ASX query.

The company could not explain the rise per se, but did point out that it had issued its quarterly report last Thursday, which was chock-full of recent significant achievements.

It also noted there had been significant market interest in a number of listed coal seam gas companies following the announcement that day by fellow coal seam gas producer QUEENSLAND GAS COMPANY (ASX:QCG) with respect to an offshore investor into its projects and its proposed LNG export project.

Qld Gas itself rose 61c to $4.03.

We could claim our part in Arrow's rise - the company was the subject of the Stock to Watch feature on Friday - but we're far too modest for that.
  Forum: By Share Code

bing
Posted on: Jan 27 2008, 01:20 PM


Group: Member
Posts: 304

In reply to: drrc on Sunday 27/01/08 09:57am


Yes drrc, interesting web site this Stop TB Partnership

http://www.stoptb.org/#cooliris



Stop TB Partnership welcomes announcement of increased US funding for global TB control
7 January 2008 -- Geneva -- During the last week of December, President George W. Bush approved US$153 million in spending for global TB control programmes for 2008--up US$72 million from 2007 spending. An additional $150 million is dedicated by the US President's Emergency Plan for AIDS Relief to address the TB-HIV co-epidemic in 2008.

Dr Marcos Espinal, Executive Secretary of the Stop TB Partnership, applauded this effort. "The U.S. should be commended for its leadership and wise investment in the global fight against TB," he said. "As a recent World Bank study concluded, the economic benefits of TB control are substantially greater than the costs. I would like to thank our partners and advocates in the U.S. Congress for their dedication and persistence. This funding increase will contribute to the implementation of the Global Plan to Stop TB; with direct benefits to men, women and children affected by TB across the globe."

  Forum: By Share Code

bing
Posted on: Jan 23 2008, 03:44 PM


Group: Member
Posts: 304

In reply to: dr_dazmo on Wednesday 23/01/08 03:49pm

Suggest you tell the management that and perhaps it makes them aware that shareholders exist.

May be they will notice something is terribly wrong. What's really going on?

Was looking forward to see our portfolio going up today but with CST going down with 10% that's was wishful thinking.

What will tomorrow bring when the overall market may go down again, what will happen to the share price then.

Are we all in denial and can't we accept that this stock is behaving irrationally?

How come there are no buyers when the profit potential of this company is so great.

What is so different about this company that it can so easily be ignored by analysts/brokers/newsletters/finance journo's ? Shouldn't we ask ourselves WHY ?

Has anyone asked management, how come ? That Cellestis is not (well) known in the investors arena.


As mentioned before, with all the good news coming out, there is still no interest in this company, no buyers.

That's why these guys can get away with their program trading.
  Forum: By Share Code

bing
Posted on: Jan 23 2008, 12:23 PM


Group: Member
Posts: 304

In reply to: rog on Wednesday 23/01/08 01:17pm

Almost everything else goes up today but this stock likes to be different it seems.

Even at these ridiculous low prices there are hardly any buyers.

Is it any wonder!

Still no news/announcement from the company?

Cellestis doesn't seem to have any consideration whatsoever for shareholders interest.

This year already down a whopping 33.4%.

Where to now?
  Forum: By Share Code

bing
Posted on: Jan 21 2008, 04:55 PM


Group: Member
Posts: 304

In reply to: SunRa on Monday 21/01/08 04:56pm

The details of IBA on Commsec are as follows

P/E ratio 11.39
Debt/Equity ratio 4.6%
Interest Cover 35.02
Quick ratio 1.04


In other words there is no debt to speak of and more over it can handle the interest with ease.

So speaking of contagion there is no such credit crunch problem what so ever.

Can't understand why this stock is hammered so much in 2008, unless the insto's are shorten this stock to do some bottom fishing.

This to my liking is happening with most stocks as the fundamentals of many have not changed all that much.

The ones who are selling/forced to sell are paying for this.

Yet the announcement to the ASX about implementation of IBA's iSoft software in 26 hospitals in Ireland you think would have had a positive influence on the share price!

Strange happenings in this share market these days.
  Forum: By Share Code

bing
Posted on: Jan 21 2008, 11:18 AM


Group: Member
Posts: 304

In reply to: coach on Monday 21/01/08 09:07am

Something is amiss, why would it drop 14% to 58c at this moment
  Forum: By Share Code

bing
Posted on: Jan 18 2008, 01:35 PM


Group: Member
Posts: 304

How many MFS shares are actually issued, because as of now more than 69million shares
have been traded.

Yet trades in BHP total a bit over 21million!

Which goes to show perhaps that institutions/traders are very active today.

Where will this all lead to.

  Forum: By Share Code

bing
Posted on: Jan 17 2008, 09:22 PM


Group: Member
Posts: 304

A possibility why the share price is sliding is perhaps explained in an article written in the Finrev today, page 42.

"Nasdaq spooks local investors"

It claims that because the Nasdaq fell 2.45% on Wednesday local IT companies were sold off.

Quote
The big sell-off came in response to more bad news triggered by the US sub-prime crisis.

In Australia, ASG Group led the pack as its share price dropped 7 per cent, shedding 11c to close at $1.44. It was followed closely by Technology One, which fell almost 6 per cent, or 6c to 95c.

Rival IT services company UXC hit a 52 week low of $1.39 in intra-day trading before recovering to close at $1.46, a fall of 4.5 per cent, or 7c, from the day before.
Investors in SMS Management and Technology lost nearly 4 per cent and ended the day 26c a share poorer at $6.26.
Local software makers were also hit. Shares in IBA Health were pruned by 6.3 per cent, or 5c to 74c after hitting a 52 week low of 72.5c

And

While the Australian technology share slump tailed a sell-off on the UN Nasdaq exchange with feverish trading in Intel, Apple, Microsoft, Cisco and Oracle shares, companies listed in Australia generally suffered bigger declines than their overseas peers.

One factor weighing on the minds of local brokers is whether locally listed IT companies, of which the vast majority are small-capitalisation stocks, can continue to fuel earnings growth by acquisition.
Unquote

Funny but IBA has an excellent debt/equity ratio of only 4.3% according to Commsec and it has no exposure to the American market.

Let's hope it recovers soon when investors find out what a good company this is.
  Forum: By Share Code

bing
Posted on: Jan 14 2008, 09:21 PM


Group: Member
Posts: 304

Posted this at another thread on SS last week but no response, try my luck here.

----------------------------------------------------

Had difficulties with PT2 today, the whole top menu bar is missing and can't get it back.

Tried to re-install but still the same problem.

Anyone else noticed the same?

This is not the first time this happened. Had to use PT1 for a long time and
tried PT2 again and the menu bar had buried itself at the bottom of the screen.

Then when I clicked on it the menu bar was installed again.

One wonders why this program is so unstable.
  Forum: Investment Discussion

bing
Posted on: Jan 14 2008, 10:45 AM


Group: Member
Posts: 304

Trading again at 11.35am and up!!!!!!!!!!!
  Forum: By Share Code

bing
Posted on: Jan 14 2008, 10:17 AM


Group: Member
Posts: 304

Funny things is that this morning at 7.05am 3 trades occurred involving
75,000 shares at $5.50 each. Hmmmmm?

3 lots

1st 60,000 shares
2nd 9,000
3rd 6,000

Thereafter there has been no further trading activity.

What's going on?

  Forum: By Share Code

bing
Posted on: Jan 14 2008, 10:13 AM


Group: Member
Posts: 304

Announcement made to ASX

A non-executive MFS director Michael Hiscock had a margin call and was forced to sell
500,000 MFS shares on Friday 11th January 2008.

Any wonder the share price was savaged.

And now there is talk that City Pacific CIY wants to merge with MFS Ltd but without the Stella Group.

See ASX announcements made this morning.

What will this mean for MFS investors?
  Forum: By Share Code

bing
Posted on: Jan 10 2008, 09:10 PM


Group: Member
Posts: 304

Good news, Chinese have bought piece of Fox

----------------------------------------------------------

Chinese snare 11pc stake in Fox Resources

Date: 10/1/2008
Author: Kate Emery
Source: The West Australian --- Page: 41
Chinese nickel producer Jinchuan has acquired an 11% stake in Western Australiannickel and copper miner Fox Resources. Stock in Fox rose $A0.015 to $A0.845 on 9January 2008 after it was revealed that Jinchuan has acquired 18.8 millionshares at $A0.95 each. Jinchuan, which will be represented on the board of Fox,will also be granted eight million options, providing it with an opportunity toincrease its holding to almost 15% within a year. Fox already has an offtake agreement with Jinchuan for its Radio Hill nickel and copper mine in the Pilbara
  Forum: By Share Code

bing
Posted on: Jan 10 2008, 08:54 PM


Group: Member
Posts: 304

This appeared in Stock Watch on CompareShares at the end of day.


Minara Resources Ltd, Australia's second largest nickel producer,
is expecting "consistent" production in 2008 after a major
maintenance program at its Murrin Murrin operation in Western Australia.
  Forum: By Share Code

bing
Posted on: Jan 10 2008, 08:48 PM


Group: Member
Posts: 304

Had difficulties with PT2 today, the whole top menu bar is missing and can't get it back.

Tried to re-install but still the same problem.

Anyone else noticed the same?

This is not the first time this happened. Had to use PT1 for a long time and
tried PT2 again and the menu bar had buried itself at the bottom of the screen.

Then when I clicked on it the menu bar was installed again.

One wonders why this program is so unstable.
  Forum: Investment Discussion

bing
Posted on: Dec 28 2007, 04:12 PM


Group: Member
Posts: 304

Received prospectus of Emu Nickel Limited in today's mail.

Apart from getting the bonus shares they are also offering priority entitlement to more shares @ 50c each.

Yet it says applications must be received no later than 31 December 2007 after which time priority will cease unless the directors extend that time.

What are they doing?

  Forum: By Share Code

bing
Posted on: Dec 20 2007, 11:48 AM


Group: Member
Posts: 304

In reply to: forrestgump on Thursday 20/12/07 12:41pm


You need to own shares with a franked dividend at least 45 days to be eligible to utilise the imputation credit. otherwise the tax office will not allow it . But you must two extra days for buy and sell days.

This is only if the total franked dividends exceeds $5,000. Under $5,000 the small shareholder exemption applies, otherwise you must satisfy the holding period and the related payments rules.
  Forum: Investment Discussion

bing
Posted on: Dec 14 2007, 04:56 PM


Group: Member
Posts: 304

In reply to: equusmedical on Friday 14/12/07 05:08pm

This is the usual stuff we experience from CST, always knocking the price down at day's close.

Confirming again again that the $3.00 level is a barrier, a resistance point of some substance it seems.

Can't understand why we remain stuck at this level, considering last year Dec 2006 the share price finished at $3.80.

And with all the good news coming out there still aren't sufficient investors interested in buying this stock and lifting the share price.

What should happen to get this stock moving; moving up that is.

And we want it to happen now!
  Forum: By Share Code

bing
Posted on: Dec 11 2007, 09:03 PM


Group: Member
Posts: 304

In reply to: bigmumma on Tuesday 11/12/07 07:52am

Today's trading just shows

"Don't count your chickens until there are hatched"

So true with this stock.

It continues to surprise us!

  Forum: By Share Code

bing
Posted on: Nov 29 2007, 07:01 PM


Group: Member
Posts: 304

In reply to: bigmumma on Thursday 29/11/07 04:05pm

Are you kidding "in the wrong direction"

Sorry to be pessimistic ,but then when you are dealing with Cellestis it is not hard to be anything else and perhaps I expect a normal trip along the investment trail. But then CST's track record is not very good.

It seems we slowly but surely are on the way again to end up falling to $2.40 again.

What a pathetic performance, almost everything goes up today but NO, CST has to be different. Again!!!

Our portfolio looks dreadful this year, thanks to Cellestis.

It is taking way too long, 6.5 years in the making now. How many years/decades do we have to wait to see a return on our investment.

What is the company offering its shareholders??? More of the same I guess. Most likely, "Please be patient", (what forever?).

It would be interesting to view the share register to find out who these people are, doing the trading. Perhaps we can find out if we periodically view the share register.
  Forum: By Share Code

bing
Posted on: Nov 29 2007, 08:48 AM


Group: Member
Posts: 304

LexisNexis Summary

MFS Limited CEO Michael King says the group has no immediate plans to sell down its stake in Stella Group.
The company has decided not to proceed with the proposed sale of a 50 per cent stake in Stella to CVC Asia Pacific.
King says the sale talks stalled because the private equity firm was unwilling to pay the price sought by MFS.

Meanwhile, MFS will acquire UK-based Global Travel, which operates some 1,200 travel agencies. MFS will also pursue travel industry acquisitions in countries such as India, China and South Africa


  Forum: By Share Code

bing
Posted on: Nov 28 2007, 03:33 PM


Group: Member
Posts: 304

In reply to: macduffy on Wednesday 28/11/07 06:36am

I am also asking the same question, WHY ?

Today with the oil price per barrel down $3.28 and BPT going down 2 cents, yet
Cooper Energy (COE) is up 2.5cents or 3.76%.

Figure that one out, when Beach has the lion share of the new discovered well!
  Forum: By Share Code

bing
Posted on: Nov 27 2007, 06:40 PM


Group: Member
Posts: 304

Beach Petroleum Makes Another Oilfield Discovery
November 27 2007 - Australasian Investment Review – (AIR)


Beach Petroluem (BPT) said on Tuesday it has discovered another oil field in the Parsons field located in West Cooper Basin, South Australia.

This follows Beach’s high volume oil discovery at the Callawonga Oilfield, also in the Cooper Basin in the last 12 months.

“Beach has now discovered oil in the Parsons field, likely to contain more than 1 million barrels of recoverable oil, close to its Callawonga, Christis and Sellicks fields,” the company said in a statement.

The discoveries are in an area virtually ignored by earlier explorers and which has now become a significantly productive area in the basin.

“The region now deserves recognition as a significant oil sub-province of the Basins,” managing director Reg Nelson said.

Beach Petroleum added 0.5 cents to $1.375.
==================================

Let's hope this will push the share price up. We need it as Beach has fallen behind some of the other oilers.
  Forum: By Share Code

bing
Posted on: Nov 23 2007, 02:09 PM


Group: Member
Posts: 304

And it is getting more ridiculous by the hour!!

Trade of 31 shares and the price drops from $2.80 to $2.74

No manipulation? Of course not - only silly buggers. What are you kidding me?

There is in my opinion definitely something fishy going on and the smell is not good.

The share performance this calendar year has been disastrous to say the least. The year 2007 has shown that this stock is worth very little. Most stocks with potential have performed reasonably well, yet Cellestis has underperformed by a large margin.

What will the share price be at year's end I ask myself.

Last year December 2006 it closed at $3.80 and during the year it touched a low of $2.25!!! A drop of 40 percent!!

Yet it can't rise above the $3.00 level as it seems to hit resistance there.

There again why is this happening when we hear such good news and rising sales figures?

Either investors who have bought at low prices and are getting fed up with the share performance are now selling and/or manipulators are at work. For what reason?

The volumes traded are nothing for traders to be interested and trades like 31 shares are surely ment to force the share price south and they can do it successfully all the time. What could be the motive behind all this?

Nothing new as I have touched this subject many times before and still there has been no posting with reasonable elucidation.

Look forward to constructive/informative discussion.
  Forum: By Share Code

bing
Posted on: Nov 17 2007, 02:21 PM


Group: Member
Posts: 304

In reply to: WannaGetRish on Tuesday 13/11/07 06:57pm

DGR got an upbeat mention this week in The Speculator's column in The Bulletin magazine.

That perhaps explains the increased interest in the share.

Bought some the other day and hoping David Haselhurst prognosis is right.

  Forum: By Share Code

bing
Posted on: Nov 3 2007, 01:46 PM


Group: Member
Posts: 304

Article from Newscientist -


"TB vaccine poses threat to HIV positive babies"


http://www.newscientist.com/channel/health...line-news_rss20
  Forum: By Share Code

bing
Posted on: Oct 7 2007, 07:02 PM


Group: Member
Posts: 304

In reply to: rene in geneva on Friday 05/10/07 09:05am

On Friday SILFX.PK dropped 15% in US, down $1.50 to close at $8.50


What can we expect tomorrow?


  Forum: By Share Code

bing
Posted on: Sep 17 2007, 04:32 PM


Group: Member
Posts: 304

Well I have the feeling that the subject of share price performance is being avoided somehow.

Let me be the first to bite the bullet and start the discussion.

Of all the shares in our portfolio on Friday last week the only one showing red was CST !!!

After such a good run and reaching a high of $3.37 recently are we heading to a sub $3 AGAIN !!

Look at what happened again today! The fun doesn't last long does it!!

Had hoped that we could see a steady rise after climbing out of that $.2.25 hole, but it doesn't seem to be the case. The last time CST traded at $3.37 was on 11th May 2007. Since then a steady decline to $2.25 and then it touched $3.37 on 10th September 2009, only to go south again.

Can't figure this out.

Look forward to some constructive comment.
  Forum: By Share Code

bing
Posted on: Sep 13 2007, 08:28 PM


Group: Member
Posts: 304

In Wednesday's 12 Sep - Finrev- Portfolio section -page 33

article

"Not all good news in oil and gas, despite price rises"

Gives information on 10 top oil exploration and production companies.
It says that "Almost all the oil and gas producers had their recent profit results marred by at least one project that was overdue, over budget ot both."

1= Market Cap($m)
2= 2006 production (million barrels equivalent)
3=P/E ratio (x)
4= 12 month share movement (%)

-------------------------------------------------
Woodside Petroleum, 1=31,290 - 2= 67.9 - 3=25.5 - 4= 20

Origin Energy, 1=8,461 - 2=12.6 - 3=19.5 - 4= 53

Santos, 1=7,439 - 2=61.0 - 3=14.4 - 4= 21

Oil Search, 1=4,110 - 2=10.2 - 3=24.5 - 4= 14

Queensland Gas, 1=1,670 - 2=1.7 - 3=235.0 - 4= 135

Arrow Energy, 1=1,456 - 2=1.5 - 3=351.0 - 4= 273

AWE, 1=1,395 - 2=3.9 - 3=7.0 - 4= 2

Beach Petroleum, 1=1,166 - 2=9.4 - 3=10.6 - 4= -12

Roc Oil, 1=955 - 2=2.0 - 3=n/a - 4= -7

AED Oil, 1=863 - 2=0 - 3=n/a - 4= 97

Nexus Energy, 1=708 - 2=0 - 3=n/a - 4= 103


Noticeable the only 2 oil companies with negative price movement are Beach Petroleum and Roc Oil !!

  Forum: By Share Code

bing
Posted on: Sep 12 2007, 07:22 PM


Group: Member
Posts: 304

In today's Finrev - AFR Profit tables were listed.
These were supplied by Morningstar

Cellestis was also listed.

Here are the details of the Preliminary Final Report.

Profit & Loss
---------------
Revenue($Mill) 19.7
ch% 101.8
Expense ($Mill) 13.3
ch% 39.9
EBIT($Mill) -3.0
ch% n.c
PreTax($Mill) -2.3
ch% n.c
Net($Mill) -2.3
ch% n.c
EPS © -2.38
Gross Mrg(%) -24.9
Net Mrg (%) -21.4

Key Ratios
---------------------------------
OCF(x) -0.705
DC (x) n.c
IC (x) n.c
RTN (x) 7.174
TLTA(x) 0.175
DTE (x) n.c
ROA (%) -14.4
ROE (%) -17.4

=============================================
Gross Mrg = Gross Profit as a percentage of Revenue
Net Mrg = Net Profit as a percentage of Revenue
OCF = Operating Clash Flow ratio
DC = Dividend cover
IC = Interest cover
RTN = Retained Earnings to Net Income
n.c = Not calculated





  Forum: By Share Code

bing
Posted on: Sep 12 2007, 07:02 PM


Group: Member
Posts: 304

With all the positive news - Why then did it drop 10c today?

  Forum: By Share Code

bing
Posted on: Sep 3 2007, 10:27 AM


Group: Member
Posts: 304

In reply to: forrestgump on Monday 03/09/07 10:12am

Hi All,

Just reading in the weekend newspaper the weekly price changes of Biostocks,

Pharmaxis Ltd up 19.71% last week!!!!!!
and Progen Pharmaceuticals up 12,22%

All caused by good news.

Let's hope Cellestis can perform likewise this week.

I has to happen one day!

I am happy with the newsletter and the marketing appointments.
  Forum: By Share Code

bing
Posted on: Aug 29 2007, 06:06 PM


Group: Member
Posts: 304

In reply to: david_j_c on Wednesday 29/08/07 04:00pm

Does not make sense in my opinion for the following reasons:

Investors must have had a dim view about Cellestis prospects for a long while now considering the slide in the share price from the all time high in Feb 2006 when the SP reached $4.70. And it continues to slide further and further.

The low volume gives rise to manipulation to the detriment of the SP as it is only going down, certainly not up. Today has shown another example of this. At 4.10pm the SP was forced down by another 7cents by two transactions of 90 shares!!!!! A value worth $208.80 each. As mentioned, the transaction taking place at 3.52pm involved a share price of $2.487 yet immediately after the SP went down by 9.7c with 536 shares traded. Figure that one out.

Certainly not all biotech's SP behave the same as Cellestis on the contrary.

As has been posted before, What will bring about a change in the performance of CST' share price? As good news seem to be discarded and in fact has a negative effect on the SP instead of a positive one, you ask yourself what change will be needed to get a higher SP. If CF+ didn't have an effect what will?

One could argue that the low volume is the cause of it all. So what can bring about a change in more volume. More awareness amongst investors?

Apart from those who say that they are willing to wait for dividends to be paid there is still an understanding that investors expect to receive a regular return for their investment be it in a rising share price or dividends. Both have been absent and there is no guarantee that the share price will go up even if dividends are paid and that may still be years away.

So the way I see it is that to increase awareness to improve liquidity a concerted effort must be made to broadcast to the world that there is such a company called Cellestis.

Please come in Mr Marketing Manager!

And Management please take note that shareholders should be taken care of as well as selling Quantiferon!

This I think is the only way we can expect a change in the direction in the SP.

Oh by the way,
Why do we want a higher SP!
Only makes sense if you want to benefit by selling some shares. Correct! The absence of dividends gives the investor a chance to be rewarded for being an shareholder in the company.

The other alternative to get out entirely is also difficult with an illiquid stock such as Cellestis as most investors do not like to accept a big loss.

  Forum: By Share Code

bing
Posted on: Aug 27 2007, 12:32 PM


Group: Member
Posts: 304

Interesting article from Ross Gittings.

Some of the contents in the article I like to highlight here;

"But when you buy a share, you have to decide what it will be worth to someone else some
time in the future."

AND

"But in financial markets, where uncertainty is pervasive, people resort to herd
behaviour."

AND

"Because herds are ruled by the majority, trends in financial markets appear to be based on little more than investors' moods.
Moods are the basis on which investors judge the way they expect other investors to value
shares in the future, so they motivate current buying and selling."

"Thus in markets for financial assets there's no tendency to "revert to the
mean" of equilibrium. There are just the ceaseless waves of social mood, fluctuating
between optimism and pessimism."

Judging by the above how do we apply this to Cellestis' SP.

=======================================================

Our bouncy market reflects a very moody herd
http://www.theage.com.au/news/business/our...dy-herd/2007/08
/24/1187462524962.html?page=fullpage#contentSwap1
Ross Gittins
August 25, 2007

ECONOMISTS don't like to think about it but, according to conventional theory, events
such as the present wild gyrations in financial markets aren't supposed to happen.

That theory says share prices move only when investors quietly incorporate new information
about the prospects of their investments, whereas it's clear the markets are swinging
between blind panic and the thought that maybe it's just a great buying opportunity. The
herd can't decide which way to run. How would you feel if you walked into a shoe shop
and the manager rushed up and told you to buy extra shoes because prices had skyrocketed? Or
if nervous customers warned you not to buy any socks because sock prices had fallen by half?

You'd feel that both the manager and his customers had taken leave of their senses. Yet
that's the kind of logic we see in financial markets all the time: people buying shares
because their price is rising and selling shares because their price is falling.

We've been witnessing sharemarkets around the world doing both those things in recent
days - sometimes both on the same day. The thing to note is that both those reactions fly in
the face of the laws of supply and demand. According to them, people buy less when the price
rises and more when it falls.

So what on earth is going wrong? Well, according to an article by Robert Prechter and Wayne
Parker, published in the Journal of Behavioural Finance, the explanation's surprisingly
simple: economists are mistaken in their assumption that the markets for financial assets
such as shares work the same way as the markets for ordinary goods and services.

That's because ordinary goods markets are subject to the laws of supply and demand, but
financial asset markets aren't. Rather, financial asset markets are subject to "the
socionomic law of patterned herding". In a market for goods and services, you have
producers on the supply side and consumers on the demand side. When prices rise, the
producers are happy to supply more of the item; when prices fall, they're willing to
supply less.

For consumers, however, it works the other way: they want to buy more when the price falls
and less when it rises.

The conflicting desires of producers and consumers create a dynamic balance, arbitrated by
price. The price will adjust until the amount producers wish to supply exactly equals the
amount consumers are willing to demand. By this mechanism, the market reaches
"equilibrium" (balance).

But, Prechter and Parker argue, the markets for shares and other financial assets don't
work that way. That's because you don't really have any producers in the market.

The supply of shares is increased when a new company floats on the stock exchange or when an
existing company makes a new share issue. But these are comparatively rare events. The vast
majority of share trades involve the exchange of existing, second-hand shares.

So, for practical purposes, there's no supply side in financial asset markets, just a
demand side. You've got demanders who want to buy and demanders who want to sell. And
the same person can be buying one day and selling the next.

"Without the governing influence of the law of supply and demand deriving from the
conflicting purposes of producers and consumers, financial prices are free to rise or fall
wherever investors' aggregate impulses take them," Prechter and Parker say.

The result is not equilibrium but unceasing dynamism. In other words, this is why share
prices are so volatile.

The next big difference between goods markets and financial asset markets is uncertainty
about current values. When a consumer (or even a producer) is buying an orange, a washing
machine or a haircut, it isn't hard to decide what it's worth to you and whether
you're prepared to pay the asking price. When you invest in a share, however, it's
much harder to know whether the price you're paying is an attractive one and whether
you're likely to be able sell the share for a good profit at some time in the future.

When you buy a good or service, you only have to decide what it's worth to you, right
now. But when you buy a share, you have to decide what it will be worth to someone else some
time in the future.

So there's far more uncertainty associated with sharemarkets and share prices - contrary
to the assumption of conventional economics and its efficient market hypothesis.

Our proponents of this "socionomic theory of finance" argue that in making
decisions about goods and services, where certainty is the norm, people use conscious
reasoning. But in financial markets, where uncertainty is pervasive, people resort to herd
behaviour.

Because herds are ruled by the majority, trends in financial markets appear to be based on
little more than investors' moods. These moods are generated "endogenously" -
that is, by factors within the system, not outside developments.

Moods are the basis on which investors judge the way they expect other investors to value
shares in the future, so they motivate current buying and selling.

Thus in markets for financial assets there's no tendency to "revert to the
mean" of equilibrium. There are just the ceaseless waves of social mood, fluctuating
between optimism and pessimism.
  Forum: By Share Code

bing
Posted on: Aug 24 2007, 01:12 PM


Group: Member
Posts: 304

What a quiet day, very little volume.

No wonder one could say, as the single-digit-volume-wreckers (SDVW) are back at work again.

Trading 3 shares and moving the share price down by 5cents.
Ridiculous or manipulated again. When is this going to stop!

Now the SDVW are back on the sell side with 3 shares. WOW and no takers since 12.06 hrs.

Would have thought CST would be contrarian again and do the same as what happened on Monday 20/8 when it was reported on this thread that All Ords went up 4.5% and CST down 7.2%.

Had hoped we could finish the week on a high and forget the listing in the Finrev that CST had hit a new low of $2.25!!! on Tuesday.
  Forum: By Share Code

bing
Posted on: Aug 21 2007, 09:45 PM


Group: Member
Posts: 304

Just visited BRR and learned that Julia Burns reports on 3rd August 2007 that Chairman Irvin Muir sold 259,000 shares at $2.59 !

How come?

The share price must have been hitting this point without anyone else witnessing this.

Not me !

www.brr.com.au

Boardroomradio - Insiders Program - Julia Burns
Friday, 3 Aug 2007 - 5.05pm

  Forum: By Share Code

bing
Posted on: Aug 20 2007, 02:54 PM


Group: Member
Posts: 304

In reply to: frootloops on Friday 17/08/07 09:15pm

It looks as if your prognosis is occurring right now.

Cellestis' SP going against the trend today, down 8c at this moment and hitting $2.40

A historical point !!! I certainly hope we are not going down further.

Hoping we are not the typical investor, who doesn't want to accept that his/her favoured stock is going down and down and doesn't want to cut losses.

I can say that at times I am exasperated by CST share price movements and wonder what to do.

When 'o' when will we see a strong and continuous strengthening in the share price.

  Forum: By Share Code

bing
Posted on: Aug 17 2007, 10:24 PM


Group: Member
Posts: 304

There is a good chance that the market has turned the corner now that the Fed has cut the bank rate by 50 basis points.

The markets in Europe are in positive territory, The FTSE is now 2.08% up!!!!!!!

This is a good sign for good trading on Monday if the Dow also closes in positive territory.

Let's hope Cellestis folllows the general trend up on Monday.

  Forum: By Share Code

bing
Posted on: Aug 9 2007, 03:09 PM


Group: Member
Posts: 304

In reply to: skorpian on Thursday 09/08/07 03:57pm

Skorpian,

None other than market cap !

There is a table of all 50 companies showing the market cap at 30 June this year and last year plus % change in market cap, Revenue 2007 and 2006 and same for net profit.

There is also a smaller table showing 10 fastest growing biotech companies. (Market Cap)
These are in order
1. Polartechnics
2. Solagran
3. Bioprospect
4. Avexa
5. Benitec
6. Clinuvel Pharmaceuticals
7. BioMD
8.ChemGenex Pharmaceuticals
9.Dia-B Tech
10. Bionomics

  Forum: By Share Code

bing
Posted on: Aug 9 2007, 02:35 PM


Group: Member
Posts: 304

An excellent article about the biotechnology sector has appeared in BRW magazine, issue 9-15th August 2007.

It ranks the Top 50 Biotech companies sorted by market cap and Cellestis ranks as number 9.

Some statistics from this ranking shows that only 12 companies are profitable and 14 show negative change in market capitalization. In the case of Cellestis it dropped 17 percent in the last financial year.

Here are some of the quotes lifted from this article.

"On the whole the biotechnology sector underperformed the broader index of small listed companies".

"Biotechnology leaders still struggle to communicate the value of their companies. This is partly a matter of honing their skills, analysts say".

"Leaders need to differentiate their audiences."
"Small shareholders need different communications than large shareholders".

"The non-investment audience is almost completely ignored by biotechnology companies because their leaders don’t understand that non-investors refer and comment on their companies".

"The best leaders are selling their company’s business strategy and product development in well-defined steps, and building investor confidence by delivering on their promises".


  Forum: By Share Code

bing
Posted on: Aug 8 2007, 09:18 PM


Group: Member
Posts: 304

Seams like it's all going well for Sunshine


The Australian Financial Review --- Page: 52 : 8 August 2007
Original article by Stephen Wisenthal



The plans of Australian coal-seam methane
explorer, Sunshine Gas, are progressing well.
It has proved and probable reserves of 224
petajoules at its Lacerta project in
Queensland. Work will begin on its production
facilities by the end of October 2007, moving
to commercial production by August 2008. Its
plans are being financed by $A30 million that
it raised in early May 2007. It also plans to
generate income by installing a gas-fired
power station[B]


Looks very promising !
  Forum: By Share Code

bing
Posted on: Aug 3 2007, 08:29 PM


Group: Member
Posts: 304

In reply to: stephen g on Friday 03/08/07 09:42am

Stephen, you misunderstood what I meant.

When I mentioned that the company should undertake a roadshow, it was not what you thought it was. Let me explain in more detail;

Doing a roadshow in the US means that you make several presentations of your company to the investment and finance industry. As such representatives/analysts from large broking houses/merchant banks and Wall Street are invited to meet the CEO of this Australian company and hear him talk about the company’s prospects. This is done to inform the market and improve awareness of the company.

Then when these representatives/analysts are happy with what they hear and after having done their own research and looked at the fundamentals, they will then recommend this stock as a Buy to their clients. A by product is that large institutions may be interested to invest if they think it is a good investment. An added bonus is that these analysts then have Cellestis on their radar and will keep on tracking the company’s profitability and inform their clients accordingly.

Quite a few Australian companies make their way to New York to do exactly this on a regular basis and the same presentations occur in Australia.

Now the next question most likely will be; Why would the Directors of Cellestis do this as it makes no difference to them personally nor the commercial aspects of the company.

But then if they would be concerned to look after shareholder interests and maintain shareholder value, i.e. a reasonable steady share price they would then realize that demand for Cellestis shares is important and something they can achieve by promoting the company to the investment community. This is something very worthwhile the company can do for its shareholders and I mention it again if they are too busy then a Director of Investor Relations could maintain good contacts.

I am also aware that some CEO’s are interviewed by Sharescene Radio, this is another avenue for them to pursue to improve awareness amongst investors. So there are many possibilities to get the company in the spotlight.

Hopefully this will result in a more balanced market depth, where there are as many buyers as sellers. Like any supply and demand situation if there is plenty supply and little demand there is downward pressure on the price. Equally the reverse happens if there is little supply and a high demand then the price goes up. If there is only a small difference between buyers and sellers then the price may go up a little or down, but not the large swings we have seen in the Cellestis share price in 2006 and 2007.

Today’s market depth is a good example what can happen to the share price when there are only a few buyers and many sellers.












  Forum: By Share Code

bing
Posted on: Aug 2 2007, 05:02 PM


Group: Member
Posts: 304

In reply to: forrestgump on Monday 30/07/07 06:12pm

Forrest,

Your question:
What do you want the Directors to do?

I don’t think you have read my previous posts but that all right I’ll copy and let you read it again.

In addition to what I mentioned before I do feel that Directors have a duty to sell not only its products but the company as well. This is a public company not a private one and Directors of public companies have additional duties to perform. Some CEO’s undertake a road show in the US and inform the market about the company’s prospects, this is done to arouse interest in the company and in particular inform investors, be they institutions or personal investors. At present there is just insufficient awareness of Cellestis and its products amongst general investors.

I have often wandered why I have never come across an article written about Cellestis in the news media. Has the CEO of Cellestis ever been interviewed by the financial news media?

Another question:
If you believe that the Directors are not doing a good job of running the business then you should say so and we can discuss that.

I do think that they may do a good job with selling Quantiferon but I don’t feel they look after shareholder interests that well. There is a need for another person to look after investor interests and I have mentioned it before a Director of Investor Relations is required in my opinion if the Directors are tooooo busy doing other things.

=========================================================

This has been posted before
(see http://www.sharescene.com/index.php?showto...&hl=cst&st=1125 and below)


Posted on: Wednesday 28/02/07 09:31pm
Replies: 12210
Views: 415182 Forrest

I have been away and have been busy reading all the posts about share price performance.

Like you Forrest I would like answers to some of the questions I have posted, but so far no luck either!

I would like to respond to some of the things you mentioned in your long post of Thursday 22nd Feb.

But first a few observations,

Scientists on the whole are naturally more focused on the technical side of the business and may not be so concerned with the financial aspects of the company. That is why we have accountant and MBA qualified CEO's.

You seem to believe that share price performance is no indication whether a company is well managed or not. Well let me tell you that with the recent reporting investors usually punish a company's share price if results are below expectation.
Equally the share price goes up if some good news has come out.

In general what determines a share price? All behavioral psychology!
It is what investors believe the company is worth. If they have a good feeling about the prospects of a company then they are prepared to pay the asking price. This is called a sellers market, however if investors have a dim view of a company then they will sell and the price is determined by the buyers, called a buyers market. (Shades of CST).

Companies are funded with investor’s money. These shareholders expect to get a return on their investment, otherwise they go elsewhere. Company directors understand that shareholders need to be rewarded and pay them a dividend or cash payment. Putting your money in an interest bearing account would be the alternative and less risky too.

So what can management do to help shareholders? Well I think that most managers feel that they should try their utmost to maximise profits. With steady or increased profits shareholders will be happy to continue investing in the company.
How do they communicate to get the message across? This they can do by telling the market what they believe are the prospects of the company. What profits do they expect this year or next year. Most companies do this regularly and it is not immoral or illegal to state what profit is expected.
Managers have a duty to inform the market says the ASX. Cellestis could do far more to get their name across and increase awareness amongst investors to make demand for their shares go up. We have touched on this subject before and discussed what management could do, i.e. talk to financial journo's, analysts, fund managers, broking firms and do this regularly. So perhaps a Director of Investor Relations could keep close contact with interested parties...

You seem to think that buying and selling shares is wrong. Let me tell you, if there was no buying or selling then we would not have a market and Cellestis would never have been able to list and get funding. Perhaps you think that the many shares which are sold and bought each day serve no purpose at all. If trading in general was not allowed we would all so much poorer.

If I you say the share price is not important why is it then that everyday share prices are quoted on the stock exchange? Why do we have indices who measure share price performance and not only in Australia but the world over.

Let me try to answer your questions.

Question 1. What do you want the Directors to do so to increase the SP?
See above. But would like to add; could it perhaps be helpful if they appoint a CEO with a business background and a reputation of being a good manager. Who knows, he or she may get better and faster results and get the company more noted by important parties.

Question 2. How would the Directors driving up the SP benefit the shareholders?
The SP will go up if "good news" is delivered to the market. What you seem to forget, is what I wrote in my previous post, is that not all of us are that rich that they can sit it out over many years to wait for a return on their investment. Of course at the time of listing most investors knew that it would take several years before a return could be expected. But how many years!
Think about it we are now 6 years after listing. Some bought CST dirt cheap others bought at much higher prices. You can expect those who sold their shares to newcomers, did sell perhaps because they needed the money to fund their lifestyle. This is what most investors do from time to time and that is, take some profits of the table. Not to sell out completely, as you suggest and no longer remain a shareholder.
Most investors who bought shares in 2006 and 2007 did so on the expectation that the share price would go up or at least stay steady for a while until fat profits would drive it much higher.

And I also have a gripe and that is that I can't understand why others can't see what is so obvious to me.

Forum: By Share Code • Post Preview: #406470
  Forum: By Share Code

bing
Posted on: Jul 30 2007, 02:46 PM


Group: Member
Posts: 304

I think it is time that we have a few posts on the company's dismal share performance.

This may upset a few people but I think we have to be objective in our criticism over the way this company looks after the interests of its shareholders, the owners of this company.

As an example of what management of a company does for its shareholders, here is a quote of one CEO.

Last week in LateLine Business the CEO of Lihir Gold was interviewed and this is what he said;

"My main role is to get value into the share price for our shareholders"

Hoping that one of the Cellestis diretors takes note of this.

You see another thing what is important for a company to aim for, is for sufficient liquidity in the share price !
=============

Here we go again, sinking below $3 mark. Had expected that we would see some improvement in the share price with last week news.

But there is obviously discontent such that the share price gets penalized and shareholders value is further destroyed.

My paper loss is getting bigger and bigger.

Each time we get good news the share price gets hammered. What's wrong with this stock I ask myself?

In meantime we are waiting for SP to go up but, when are we to see a determined uptrend.

There are those who say, Patience, patience mate, she’ll be rite.
When though? How much longer do we have to wait to see results.


Then again there is something very strange happening with this stock when trades of 1 share transactions are occurring. Like this morning at opening 6 shares were traded and the SP drops 6 cents. Who would be interested in such a transaction?
Traders!!!
What, making 10c profit and what about transaction cost?

Crazy the way this stock is kicked around and management just seem able to ignore shareholders concern, perhaps because nobody asks any pertinent question as to what their ultimate goal is for shareholders.

What are we to make of all these transactions of 1 to 10 shares? This is happening on the buy and sell side. Only to see the share price being further and further eroded.

Have a look at the CST graph. Finishing at $3.80 at the end of Dec 2006, then what we see is a channel of lower highs and lower lows and dipping below $3.00 and retesting it again today. Yet this is all happening against a background of better and better sale figures.

WOW certainly a unique performance!

Most companies would reflect this with an up trending share price, but not Cellestis. WHY!!!!!!!

Perhaps we should ask for a special shareholders meeting and ask the Board what recognition shareholders get in this company and perhaps a Director of Investor Relations position should be created to better look after shareholders interest.

Any other concerned investor out there daring enough to constructively contribute to my post?


  Forum: By Share Code

bing
Posted on: Jul 23 2007, 09:00 PM


Group: Member
Posts: 304

Currency change

The AUD appreated against major currencies in the past 12 months as per below

USD 16.73%

YEN 22.91%

EURO 6.28%
  Forum: By Share Code

bing
Posted on: Jul 21 2007, 12:34 AM


Group: Member
Posts: 304

I am interested in StockResource as a Newsletter.

If any of you has been a subscriber, then would like to have some feedback w.r.t quality of report/recommendation and value for money.

Thanks Bing
  Forum: Off Topic Chat

bing
Posted on: Jul 2 2007, 09:49 AM


Group: Member
Posts: 304

In reply to: daggie on Sunday 17/06/07 06:52pm

According to an article which appeared in the Weekend Finrev

Quote
The most bizarre thing in recent weeks is that it is the predator's share price that has been rising, not that of the target.

This reflects the broad market view that price tension has been removed from the auction and Wesfarmers may be able to get Coles on the cheap.

Wesfarmers shares have also been helped by the rise in the coal price outlook(for its large coal business) and the realisation among institutional investors that they need to start building a bigger Wesfamrers position because it will be a large part of the index if, as is likely, it uses a significant amount of its own scrip as consideration in its bid for Coles.
Unquote

Hope this answers your question !
  Forum: By Share Code

bing
Posted on: Jun 22 2007, 04:16 PM


Group: Member
Posts: 304

Happening again !!!!!!

At 4.05pm somebody placed an order to sell 37 shares for $2.78
and the on the buy side 4000 shares at $3.07 was offered.

The closing price stood at $3.02

They are desperately trying to force the price down at the last moment.

What is their AIM !!!!!!!!!!!

Whilst writing this another buyer came in wanting to buy 5000 shares.

In the end at 4.10pm 2 trades went through both for $3.08 and one was the 37 shares !!

What a day it has been, but at least there was more volume (128,223) and more trades (86).

Let's see what happens next week.
  Forum: By Share Code

bing
Posted on: Jun 18 2007, 09:39 PM


Group: Member
Posts: 304

In reply to: Brierley on Monday 04/06/07 01:45pm

Had difficulties with PT2 today, the whole top menu bar is missing and can't get it back. Tried to re-install but still the same problem.

Contacted Commsec and asked for Tech Support but they still have to phone me back.

However received a link where one can download the exec file for PT1.

Made sure I've stored it in my Downloads folder for future use if I have to reformat.

Here it is

http://images.comsec.com.au/downloads/prot...aderinstall.exe

  Forum: Investment Discussion

bing
Posted on: Jun 14 2007, 10:04 AM


Group: Member
Posts: 304

At opening someone selling

10,000 shares at wait wait for


$2.02


WOW

  Forum: By Share Code

bing
Posted on: Jun 13 2007, 08:38 PM


Group: Member
Posts: 304

Kalmsg,

I would love to comment but can't because I find it very difficult to say anything for or against.

What is troubling though is the drop in the share price of 30c in one week or 18.5%.

Where do you think we may end up with the share price. BTW I am still holding.
  Forum: By Share Code

bing
Posted on: Jun 13 2007, 09:55 AM


Group: Member
Posts: 304

AND there is more

At 9.54am someone wants to sell 13,107 shares at $3.00 and
another 20,000 shares at $2,99 and 59 shares at $2,96.

Where are we heading?
  Forum: By Share Code

bing
Posted on: Jun 8 2007, 10:06 PM


Group: Member
Posts: 304

Skorpian,

All these small trades are a mystery. Normally Comsec does not accept any trades below $500 worth, so who could be doing this, brokers!!!!

Today at closing time there was a buy order for $3.07 and someone tried to sell at $2.94, the last trade went through at $3.19. I watched the last two trades going through, i.e.
at 16.10 hrs 19 shares @ $3.19 and at the same time 31 shares @ $3.19.

Then when time ticked away, what happened was that the sell order of $2.94 disappeared.

There was obviously an attempt to bring the price down to below yesterday's close of $3.07 but they didn't succeed.

Who would be interested in lowering the share price? Well perhaps someone who likes to grab a large parcel at cheap prices.

It is scary watching the gyrations of the share price.

As a reminder last year at 30th June 2006 the share price closed at $3.95.

Will be interesting to see where it will end up this time.

Something to think about; when will the share price rid itself of the shackles and starting trending up?

  Forum: By Share Code

bing
Posted on: Jun 7 2007, 09:36 PM


Group: Member
Posts: 304

Have a look at the today's trades.

38 Trades and a volume of 22,233 shares.

Good stuff or what?

Just shows there is no liquidity at all.

When o when will this change.

No news, no matter how good has made any significant change to the share price in the past.

So what can bring about a change to get the share price stabilised or go up?

Time Price Volume Value Conditions
07/06/2007 04:10:22 3.07 45 138.15 F
07/06/2007 04:10:22 3.07 225 690.75 G
07/06/2007 04:10:22 3.07 21 64.47 F
07/06/2007 03:57:05 3.08 2754 8482.32 F
07/06/2007 03:57:05 3.08 246 757.68 G
07/06/2007 03:55:42 3.11 730 2270.30 G
07/06/2007 03:47:59 3.11 77 239.47 F
07/06/2007 03:47:59 3.11 3 9.33 F
07/06/2007 03:27:50 3.08 32 98.56 F
07/06/2007 03:27:50 3.08 24 73.92 F
07/06/2007 03:27:50 3.08 17 52.36 F
07/06/2007 02:58:24 3.08 1996 6147.68 F
07/06/2007 02:58:08 3.08 657 2023.56 F
07/06/2007 02:45:37 3.08 28 86.24 F
07/06/2007 02:44:49 3.1 843 2613.30 G
07/06/2007 02:03:13 3.1 1 3.10 F
07/06/2007 02:03:13 3.1 16 49.60 F
07/06/2007 01:50:24 3.1 40 124.00 F
07/06/2007 01:50:24 3.1 120 372.00 XT G
07/06/2007 01:21:00 3.1 18 55.80 F
07/06/2007 12:38:36 3.1 13 40.30 F
07/06/2007 12:38:36 3.1 11 34.10 F
07/06/2007 12:38:36 3.1 21 65.10 F
07/06/2007 12:38:36 3.1 9 27.90 F
07/06/2007 12:38:36 3.1 49 151.90 F
07/06/2007 12:06:49 3.1 2759 8552.90 XT F
07/06/2007 12:06:49 3.1 2000 6200.00 XT G
07/06/2007 12:06:49 3.1 241 747.10 G
07/06/2007 11:56:23 3.1 4 12.40 F
07/06/2007 11:56:23 3.1 45 139.50 F
07/06/2007 11:15:40 3.11 647 2012.17 G
07/06/2007 11:14:00 3.11 38 118.18 F
07/06/2007 10:55:00 3.11 15 46.65 F
07/06/2007 10:22:59 3.12 488 1522.56 G
07/06/2007 10:17:20 3.12 3000 9360.00 F
07/06/2007 10:02:18 3.15 4742 14937.30 XT G
07/06/2007 10:02:18 3.15 200 630.00 XT F
07/06/2007 10:02:18 3.15 58 182.70 F
  Forum: By Share Code

bing
Posted on: May 25 2007, 09:36 AM


Group: Member
Posts: 304

Good to see another post, I thought for a while that all Sharescene investors had lost interest in NUP.

  Forum: By Share Code

bing
Posted on: May 25 2007, 09:32 AM


Group: Member
Posts: 304

Frankfurt stock exchange shows a lift in ARU shareprice of 5.05% today.

  Forum: By Share Code

bing
Posted on: May 21 2007, 05:25 PM


Group: Member
Posts: 304

Nice performance today, hopefully it will continue going north
  Forum: By Share Code

bing
Posted on: May 21 2007, 05:23 PM


Group: Member
Posts: 304

Is to be expected with a stock where the buyers hold sway.

There is no demand for this stock, that's why.

At close of business today volume on the sell side 403,079 and on the buy side 71,970.

Almost six times more sellers than buyers.

And this is excluding the ones who sneek in to sell at even lower prices than what is quoted.

  Forum: By Share Code

bing
Posted on: May 18 2007, 03:19 PM


Group: Member
Posts: 304

Macquarie Research Equities came out today with a recommendation to buy.

It is offering two short-dated installment warrants in WSA.

Nice to know they are also recognizing the potential of Western Areas.


http://www.macquarie.com.au/wasp/dailytrad...pickofday_1.htm


  Forum: By Share Code

bing
Posted on: Apr 22 2007, 07:54 AM


Group: Member
Posts: 304

In reply to: kalmsg on Saturday 21/04/07 01:38pm

Thanks kalmsg.

Had a look and noticed also that there is quite a difference the day changes (%) between the various boerses.


Let's hope it can be repeated here on Monday.

  Forum: By Share Code

bing
Posted on: Apr 20 2007, 09:15 AM


Group: Member
Posts: 304

In reply to: emem8888 on Thursday 19/04/07 08:02pm

Had a look at Yahoo!Finance but there are 4 listings in Germany.

REB.F Frankfurt quotes Euro 1.03

REB.MU Munich Euro 1.04

REB.BE Berlin Euro 1.00

REB.DE XETRA Euro 1.04


Which one you think is the most important for us here and are they indicative for our market or is it the other way around?

Hard to forecast what will happen today, further south or consolidating !

  Forum: By Share Code

bing
Posted on: Apr 19 2007, 05:38 AM


Group: Member
Posts: 304

In reply to: emem8888 on Wednesday 18/04/07 02:33pm

Same here, I am also in it for the long haul. Nice if it climbs back up again here too.

Could you tell where you obtain this info about the German listing?

  Forum: By Share Code

bing
Posted on: Apr 16 2007, 11:20 PM


Group: Member
Posts: 304

In reply to: chariot20030 on Monday 16/04/07 02:18pm

Yes agree.

Held onto my allotment during the high of $1.65 and still holding.

But then bought some more at 82c, thinking it may go back up and test new highs as facts have not changed.

  Forum: By Share Code

bing
Posted on: Mar 19 2007, 07:58 PM


Group: Member
Posts: 304

My CommSec holding is still showing EXT and the total number of shares is also the same.

Will we get notified by Extract Resources about the changes which have occurred?

Expect to see the SP gyrating towards the 80c following the latest funds raising deal.







  Forum: By Share Code

bing
Posted on: Mar 16 2007, 01:28 PM


Group: Member
Posts: 304

SP holding up quite well sofar.

Keep going north mate

  Forum: By Share Code

bing
Posted on: Feb 28 2007, 08:31 PM


Group: Member
Posts: 304

Forrest

I have been away and have been busy reading all the posts about share price performance.

Like you Forrest I would like answers to some of the questions I have posted, but so far no luck either!

I would like to respond to some of the things you mentioned in your long post of Thursday 22nd Feb.

But first a few observations,

Scientists on the whole are naturally more focussed on the technical side of the business and may not be so concerned with the financial aspects of the company. That is why we have accountant and MBA qualified CEO's.

You seem to believe that share price performance is no inidication whether a company is well managed or not. Well let me tell you that with the recent reporting investors usually punish a company's share price if results are below expectation.
Equally the share price goes up if some good news has come out.

In general what determines a share price? All behavioral psychology!
It is what investors believe the company is worth. If they have a good feeling about the prospects of a company then they are prepared to pay the asking price. This is called a sellers market, however if investors have a dim view of a company then they will sell and the price is determined by the buyers, called a buyers market. (Shades of CST).

Companies are funded with investors money. These shareholders expect to get a return on their investment, otherwise they go elsewhere. Company directors understand that shareholders need to be rewarded and pay them a dividend or cash payment. Putting your money in an interest bearing account would be the alternative and less risky too.

So what can management do to help shareholders. Well I think that most managers feel that they should try their utmost to maximise profits. With steady or increased profits shareholders will be happy to continue investing in the company.
How do they communicate to get the message across? This they can do by telling the market what they believe are the prospects of the company. What profits do they expect this year or next year. Most companies do this regularly and it is not immoral or illegal to state what profit is expected.
Managers have a duty to inform the market says the ASX. Cellestis could do far more to get their name across and increase awareness amongst investors to make demand for their shares go up. We have touched on this subject before and discussed what management could do, i.e. talk to financial journo's, analysts, fund managers, broking firms and do this regularly. So perhaps a Director of Investor Relations could keep close contact with interested parties..

You seem to think that buying and selling shares is wrong. Let me tell you, if there was no buying or selling then we would not have a market and Cellestis would never have been able to list and get funding. Perhaps you think that the many shares which are sold and bought each day serve no purpose at all. If trading in general was not allowed we would all so much poorer.

If I you say the share price is not important why is it then that everyday share prices are quoted on the stock exchange? Why do we have indices who measure share price performance and not only in Australia but the world over.?

Let me try to answer your questions.

Question 1. What do you want the Directors to do so to increase the SP?
See above. But would like to add; Could it perhaps be helpful if they appoint a CEO with a business backgorund and a reputation of being a good manager. Who knows, he or she may get better and faster results and get the company more noted by important parties.

Question 2. How would the Directors driving up the SP benefit the shareholders?
The SP will go up if "good news" is delivered to the market. What you seem to forget, is what I wrote in my previous post, is that not all of us are that rich that they can sit it out over many years to wait for a return on their investment. Of course at the time of listing most investors knew that it would take several years before a return could be expected. But how many years!
Think about it we are now 6 years after listing. Some bought CST dirt cheap others bought at much higher prices. You can expect those who sold their shares to newcomers, did sell perhaps because they needed the money to fund their lifestyle. This is what most investors do from time to time and that is, take some profits of the table. Not to sell out completely, as you suggest and no longer remain a shareholder.
Most investors who bought shares in 2006 and 2007 did so on the expectation that the share price would go up or at least stay steady for a while until fat profits would drive it much higher.

And I also have a gripe and that is that I can't understand why others can't see what is so obvious to me.
  Forum: By Share Code

bing
Posted on: Feb 22 2007, 01:52 PM


Group: Member
Posts: 304

In reply to: skorpian on Thursday 22/02/07 02:38pm

Skorpian.

I it was intended to be one and the same.

The product is good but the SP is not reflecting that at all!
  Forum: By Share Code

bing
Posted on: Feb 22 2007, 01:33 PM


Group: Member
Posts: 304

We may well ask ourselves, who's at fault here.

We have a fantastic product yet no emphasis is placed at all on share price performance.

What signal does this send out to the wider community!

Where buyers are in control and constantly force the price down and play around with it at will. Who would like to own a piece of that!

And as you say "whenever some Good news comes out the SP is sold Down"

When will this change? What needs to be done to bring about a change for the better?

Nobody seems to have an answer as to how and when this non-directional move of CST' share price is going to stop.

There is no support therefore no demand to buy this product and this will continue indefinately until everybody knows about Cellestis.

Some like to think that COH and CST are similar. Look at the chart and compare Cochlear and Cellestis in the first 6 years since listing. There is no comparison!

Six years since listing Cochlear' SP steadily went up until it peaked at $52.00 and Cellestis peaked at $3.37 on 14th November 2001 and then after a rollercoaster ride we are almost there again after 5 years and a bit!

After shrugging off some stiff competition Cochlear is now worth close to $60.00 a share.

What can we expect from Cellestis?






  Forum: By Share Code

bing
Posted on: Feb 21 2007, 01:39 PM


Group: Member
Posts: 304

In reply to: Starman on Wednesday 21/02/07 01:36pm

Yes I agree with your calculations and it makes sense.

Let's hope it will get better with time for both shares upon listing of NTU.



  Forum: By Share Code

bing
Posted on: Feb 20 2007, 08:46 AM


Group: Member
Posts: 304

Something strange happened yesterday at close of trade.

The whole day the SP hovered over $3.48/$3.49

Then after 3.30pm it traded at $3.50 reaching $3.52 at 3.58pm.

This would have given a rise of 4 cents over Friday’s close.

But then at 4.10pm a trade goes through at $3.47 for 33 shares.!!

Accepting 5cents less for 33 shares!!!!

I don’t think this trade was related to the last trade before.

So finishing the day at 1cent down on Friday’s close.

Strange, very strange

Or is there something more sinister at work here?
  Forum: By Share Code

bing
Posted on: Feb 19 2007, 02:55 PM


Group: Member
Posts: 304

I think the discussion we are having is very good as our attention should focus on SP performance.

Something what still bothers me is that nobody yet has been able to explain the following;

Why is it that CST’ share price is not reflecting the immense potential of Qantiferon as a product. Which we all know is not like selling a TV but repeat business over and over again.

Other listed companies share price rise like a rocket by the mere smell of future profits, which Quantiferon can produce, yet there is so little demand for CST shares.

Why is there so little interest? It can’t be because only few people are aware of CST existence? Or if that is the reason shouldn’t management start a road show and get the name of Cellestis on everybody’s lip. Some could say why should management do this?

Well this is exactly the point I like to make, when will the SP take off
.
Only if demand goes up and that means only if more investors know about Cellestis.

Good sales figures in the past did not have an effect on the SP. Why should it be different later on?

And,

If we are not expecting good dividends and full franking how else can we derive a return on our investment. Capital gains may be happening in the beginning and selling some shares is OK but for long term investors income becomes an important issue.

When Quantiferon sales reach stellar proportions and fat profits are made then good dividends should be paid to shareholders.
.




  Forum: By Share Code

bing
Posted on: Feb 19 2007, 08:16 AM


Group: Member
Posts: 304

In reply to: kelpie on Sunday 18/02/07 03:26pm

WOW a new post mentioning share price performance! Not often seen on this thread.

Why I ask myself, isn't Sharescene supposed to be a forum for investors discussing mainly share price performance and also company products and policy?

Yet this thread here barely discusses share price performance and dare I mention return on investment.

But first a bit of history, this week exactly one year ago on 15th February 2006 Cellestis share price reached an intraday high of $4.72 and closed at $4.63.

On Friday 16th February 2007 it closed at $3.48, a difference of $1.15 or a drop of 24.83%. Not so good for those who bought at these lofty prices in February 2006.

The ASX200 has scored much better, in the past 12 months it went up 24.04%

There are those who say that they are not interested in the share price but then not all of us are that rich to ignore a decent return on investment.

The fact is that money invested by investors a year ago to support Cellestis all this time has seen no return at all, on the contrary their investment has dropped considerably in value.

There is a cost associated to money and the opportunity cost of investing in CST shares has cost us all a lot. If we would have invested in an ASX200 index (ETF) we would be better of by 24.03%, yet we have gone back 24.83%, combined a staggering 48.86% difference.

One cannot ignore these facts. I and other people I know have added shares north of $4.00 probably thinking that it would be a prudent investment at the time.

Some people may hold Cellestis shares in their DIY retirement portfolio and need to get a decent return comprised of dividends and capital gain to fund their lifestyle. It seems that most people posting on this forum are probably deriving an income from employment.

Reason that I still hold Cellestis shares and not sold out is because I believed that it would turn the corner soon and did not want to accept a big loss on our investment.

The prospect of this fantastic product selling millions of kits each year and the expectations held by so many on this thread gave me assurance it would come right soon.

It has been said that once positive cash flow has been established, the wider community will take notice and demand will go up, causing the share price to rise. But the gyrations of the share price even after the recent good figures of the 2nd half of 2006 have not had the desired effect. On the contrary it was knocked down again this week finishing at $3.48.

So why would it change for the good later on when more good figures are released? Past performance is not a good indicator. I sincerely hope I am wrong. Comparing Cellestis with other companies with similar signs of future profits show much better share price performance.

But then I ask myself what does the company do for it shareholders who have invested their hard earned money.

What are they thinking!

They should feel an obligation to give shareholders a return on their investment. Why would shareholders otherwise invest in Cellestis!

Other publicly owned companies realise that shareholder value must be maintained and are interested to provide information about expected future results.

This I feel is lacking with the management of Cellestis. There is no recognition as such that they have a responsibility to explain to shareholders and the market what can be expected as far as monetary results are concerned. Other public companies make an effort to let the market know what they are up to.

Why is it that after six years since listing there is still so little interest in Cellestis?
The daily trading in Cellestis shares is dominated by buyers who constantly are allowed to force the share price down.
What will make this situation change its course? There are those who say, "Once profits are there then the instos will take notice".

Well you could also say these people working for the instos are not stupid and can see an opportunity for a good investment when they see one. They may be prepared to invest in these type of companies at an early stage if they belief there is a good chance to make a buck.

So will this really change once Cellestis declares a profit? I have doubts about that. What will make a change however is when management goes out of their way to explain to shareholders and the market what expectations it has about financial aspects in the next 12 months or even 6 months.

Then I think we will see a change, once investors know that there is a good chance to make a capital gain.

Dividends of say 4 to 5 percent and 100% franked are very good but there again we also like to see a small capital gain each year. For Cellestis to be regarded as a good investment from the time money was invested it requires a huge rise in the share price to wipe out the paper losses investors have incurred.
  Forum: By Share Code

bing
Posted on: Feb 7 2007, 08:53 PM


Group: Member
Posts: 304

In reply to: rossw on Wednesday 07/02/07 01:56pm

Same here, another GT subscriber.

I also got stopped out and didn't get back in. Spend the money elsewhere, but now got back in at $1.40.

Pity I didn't get back in sooner but then did well with my other investment.

So really no regrets at all.

  Forum: By Share Code

bing
Posted on: Feb 1 2007, 09:17 AM


Group: Member
Posts: 304

In reply to: rog on Wednesday 31/01/07 07:41pm

What growth!! Where

Not in the share price. All we seem to do there is going backwards instead of forward.

Looks to me we have another resistance point at $3.80.

Perhaps a base to go south again not north.

  Forum: By Share Code

bing
Posted on: Jan 18 2007, 02:36 PM


Group: Member
Posts: 304

Just picked up a Finrev and there is an article on page 13 about coal.

"Bottlenecks add steam to coal price"

In general it mentions a coal price increase, not only for thermal coal but also low-volatile PCI.

It goes on to say "This will boost profits at Macarthur Coal - the biggest exporter of low-volatile PCI- which GSJBW has upgraded to "outperform" from "market perform"".

As MCC SP rose 17c yesterday perhaps some are taking profits of the table today.

  Forum: By Share Code

bing
Posted on: Jan 18 2007, 12:44 PM


Group: Member
Posts: 304

Meghan the report was from

Sonray Morning Equities Report.

Surely this situation re: CEO & Minister must have occurred a while ago now. Why has the market reacted today by marking it down.

Noticed it slowly crawls back from a low of $5.18
  Forum: By Share Code

bing
Posted on: Jan 18 2007, 11:46 AM


Group: Member
Posts: 304

This appeared in the morning equities report

Quote

Market Comment
More private equity rumours yesterday as CSR looks the likely
target of a $4.30 bid according to market whispers. Congolmerates
like CSR make good targets as they can be broken up and worth
more as the sum of the parts. Another theme for trades is the Coal
sector – keep and eye on over sold coal stocks such as MCC, and
Centennial.

Unquote

If it is oversold how come the SP is going down !

  Forum: By Share Code

bing
Posted on: Jan 16 2007, 12:02 PM


Group: Member
Posts: 304

Financial Review - Tuesday 16th Jan 2007 - page 18

article - "Biotechs attract attention" by Helena Keers

Cellestis got a mention today - not a very glowing one though.

  Forum: By Share Code

bing
Posted on: Jan 10 2007, 08:02 AM


Group: Member
Posts: 304

In reply to: richmond on Monday 08/01/07 01:20pm

Clarification of NT News Article re: Angela and Pamela Uranium deposits.




http://aspect.comsec.com.au/asxdata/200701...df/00683746.pdf



No company involvement it seems!



Mr McCleary is a Top 20 shareholder who has acted on his own.
  Forum: By Share Code

bing
Posted on: Jan 8 2007, 09:47 PM


Group: Member
Posts: 304

hi wolverine,

Yes I did that for a while but have since moved to CFD's for trading.

Not been overly happy with my record sofar but hopefully 2007 will be a better year.

Any good tips are always welcome.


Bing
  Forum: By Share Code

bing
Posted on: Jan 8 2007, 04:55 PM


Group: Member
Posts: 304

WOW what a day this was.

First it gapped down and then reached a low of $4.74 and finished down 33c and 6.48%.

What caused this enormous bloodletting?

The market in general is down but this looks to be a bit overdone.

  Forum: By Share Code

bing
Posted on: Dec 27 2006, 10:12 AM


Group: Member
Posts: 304

Just noticed that ARU has lodged a prospectus with the ASX, talking about a demerger!!!!!

What's this all about.

Looked at my Comsec holding and it was added to my holding of ARU shares today.

  Forum: By Share Code

bing
Posted on: Dec 13 2006, 07:38 PM


Group: Member
Posts: 304

Something very strange happened at the end of day trading.

In the last 15mins of trading IAG share price dropped from $6.00 to $5.89.

Between 16.10 hrs and 16.44hrs a lot of transactions took place.

Some were very small but other very big. In fact a total 134 trades went through after 16.10hrs.

Some big trades
at 16.25 hrs - 542,224 shares at $5.89 worth $ 3million,
at 16.26hrs - 200,000 shares at $5.89 worth $1,1 million
at 16.44hrs - 151,290 shares at $6.047 worth $914,850

No idea what this means!!


  Forum: By Share Code

bing
Posted on: Nov 13 2006, 03:53 PM


Group: Member
Posts: 304

About time I should say something again, not that I am the bearer of good news.

The market has been closed 45mins ago and no response yet about the miserable share price performance of CST today.

A whopping 5.76% down.

Well we are used to these abnormal movements!!!!!!!

On 29th Sept 2006 it gapped down and finished with a drop of 7.23%, and 30th August down 6.34% and so on. Has gone up with similar numbers in the past but that was from a low base. To be expected.

But then this time most people had expected a better EOD result, especially on the day of the AGM.

Maybe bad news surfaced at the meeting. Soon we'll know.
  Forum: By Share Code

bing
Posted on: Nov 3 2006, 10:42 AM


Group: Member
Posts: 304

What's happening?

SAU lagging

Look what happened to ITT's share price this morning, up 28.5%!!!!!!

Same Gawler Craton exploration company!!!

Does anyone have an explanation why SAU's share price is not performing?
  Forum: By Share Code

2 Pages (Click to Jump) V   1 2 >

Cant find what you are looking for? Show all active topics from the last 3 months


New Posts  New Replies
No New Posts  No New Replies
Hot topic  Hot Topic (New)
No new  Hot Topic (No New)



TERMS OF USE  -  CONTACT ADMIN  -  ADVERTISING